<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm: Cefuroxime</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest headlines from journals and sites in the Cefuroxime category.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Cefuroxime&t=Cefuroxime&f=drugs&s=Search&r=Any&o=d]]></link>
        <lastBuildDate>Sat, 20 Mar 2010 17:39:48 +0100</lastBuildDate>
        <item>
            <title>Antibiotics for community-acquired pneumonia in children.</title>
            <link>http://www.medworm.com/index.php?rid=3383634&amp;cid=c_8_22_f&amp;fid=38107&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20238334%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: There were many studies with different methodologies investigating multiple antibiotics. For treatment of ambulatory patients with CAP, amoxycillin is an alternative to co-trimoxazole. With limited data on other antibiotics, co-amoxyclavulanic acid and cefpodoxime may be alternative second-line drugs. For severe pneumonia without hypoxia, oral amoxycillin may be an alternative to injectable penicillin in hospitalised children; however, for ambulatory treatment of such patients with oral antibiotics, more studies in community settings are required. For children hospitalised with severe and very severe CAP, penicillin/ampicillin plus gentamycin is superior to chloramphenicol. The other alternative drugs for such patients are ceftrioxone, levofloxacin, co-amoxyclavulanic acid and...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Cochrane Database of Systematic Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3383634</comments>
            <pubDate>Sat, 20 Mar 2010 06:22:03 +0100</pubDate>
            <guid isPermaLink="false">3383634</guid>        </item>
        <item>
            <title>Comparative in vitro activity of tigecycline and other antimicrobial agents against Shigella species from Kuwait and the United Arab of Emirates</title>
            <link>http://www.medworm.com/index.php?rid=3357559&amp;cid=c_8_46_f&amp;fid=38418&amp;url=http%3A%2F%2Fwww.jiph.org%2Farticle%2FPIIS1876034109000811%2Fabstract%3Frss%3Dyes</link>
            <description>In conclusion, Shigella spp. isolated from symptomatic patients in Kuwait and the UAE demonstrated high rates of resistance to the first-line antibiotics but very susceptible to the carbapenems, cephalosporins, fluoroquinolones and tigecycline. Tigecycline holds promise as a potential drug of choice for the therapy of severe shigellosis. (Source: Journal of Infection and Public Health)</description>
            <author>Journal of Infection and Public Health</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3357559</comments>
            <pubDate>Fri, 12 Mar 2010 15:45:07 +0100</pubDate>
            <guid isPermaLink="false">3357559</guid>        </item>
        <item>
            <title>CEFUROXIME SODIUMinjection, Powder, For Solution [Samson Medical Technologies, L.L.C.]</title>
            <link>http://www.medworm.com/index.php?rid=3355925&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D16284</link>
            <description>Updated Date: Mar 11, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355925</comments>
            <pubDate>Thu, 11 Mar 2010 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">3355925</guid>        </item>
        <item>
            <title>Emerging</title>
            <link>http://www.medworm.com/index.php?rid=3346212&amp;cid=c_8_77_f&amp;fid=33833&amp;url=http%3A%2F%2Fwww.ijmm.org%2Farticle.asp%3Fissn%3D0255-0857%3Byear%3D2010%3Bvolume%3D28%3Bissue%3D1%3Bspage%3D51%3Bepage%3D53%3Baulast%3DVerma</link>
            <description>Verma S, Thakur S, Kanga A, Singh G, Gupta PIndian Journal of Medical Microbiology 2010 28(1):51-53This retrospective study incorporates a six years, six months (January 2000-June 2006) laboratory data comprising 258 isolates of Salmonella. Cultures were identified by standard methods. Salmonella enterica serotype Typhi (S.Typhi) was the more frequent serotype isolated i.e., 61.62&amp;#x0025; with the remaining 38.37&amp;#x0025; being Salmonella enterica serotype Paratyphi A (S. Paratyphi A). There was emergence of S. Paratyphi A as the predominant serotype in 2003-2004 with resurgence of serotype Typhi thereon. A total of 66.27&amp;#x0025; isolates were resistant to one or more antibiotics. MDR S. Typhi was 10.69&amp;#x0025; and while 13.13&amp;#x0025; were MDR S. Paratyphi A. There was decrease in resistanc...</description>
            <author>Indian Journal of Medical Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3346212</comments>
            <pubDate>Tue, 09 Mar 2010 17:15:51 +0100</pubDate>
            <guid isPermaLink="false">3346212</guid>        </item>
        <item>
            <title>Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus.</title>
            <link>http://www.medworm.com/index.php?rid=3354950&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20211890%26dopt%3DAbstract</link>
            <description>Authors: Nannini EC, Stryjewski ME, Singh KV, Rude TH, Corey GR, Fowler VG, Murray BE
    Using 98 clinical MSSA isolates of known beta-lactamase (Bla) type, we found a pronounced inoculum effect for cephalexin (mostly Bla type A and C strains), mild for cephalothin (especially type B and C), and nonexistence for ceftriaxone and cefuroxime. Ceftobiprole showed the lowest MICs at high inoculum but with a slight increase for Bla-positive versus Bla-negative strains. Since a potential therapeutic effect associated with a cephalosporin inoculum effect has been described, further studies are warranted.
    PMID: 20211890 [PubMed - as supplied by publisher] (Source: Antimicrobial Agents and Chemotherapy)</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3354950</comments>
            <pubDate>Mon, 08 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3354950</guid>        </item>
        <item>
            <title>[Changes in the antimicrobial susceptibility of Escherichia coli isolates from community diagnosed urinary tract infections during the period 2003-2007. Multicentre study in Castilla la Mancha (Spain).]</title>
            <link>http://www.medworm.com/index.php?rid=3374899&amp;cid=c_8_13_f&amp;fid=37253&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20232022%26dopt%3DAbstract</link>
            <description>Conclusions: We observed a significantly reduction of E. coli susceptibility for most antibiotics and an increase of E. coli isolates producing ESBLs. Fosfomycin and nitrofurantoin are the best choices for empiric treatment. Prospective studies should be performed in the future to confirm the results of our study.
    PMID: 20232022 [PubMed - in process] (Source: Revista Espanola de Quimioterapia)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Revista Espanola de Quimioterapia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3374899</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3374899</guid>        </item>
        <item>
            <title>Acute Intravascular Haemolysis Associated with Intravenous Administration of Meropenem in a Sixty Four Year Old Man.</title>
            <link>http://www.medworm.com/index.php?rid=3263621&amp;cid=c_8_13_f&amp;fid=37739&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20147773%26dopt%3DAbstract</link>
            <description>We present the first reported case of severe intravascular haemolysis associated with the use of meropenem in a 64 year old man. The report highlights a further possible drug related cause of intravascular haemolysis. The patient, who had a background of dialysis dependent renal failure, epilepsy and learning difficulties, was admitted to the intensive care unit following laparotomy and large bowel resection. His background also included a reported childhood allergy to penicillin. Along with initial haemodynamic and ventilatory support he was treated with cefuroxime, metronidazole and gentamicin without incident. He went on to develop an abdominal collection, for which treatment included meropenem. Associated with the administration of meropenem was the development of severe intravascular ...</description>
            <author>The Canadian Journal of Clinical Pharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3263621</comments>
            <pubDate>Fri, 12 Feb 2010 12:10:04 +0100</pubDate>
            <guid isPermaLink="false">3263621</guid>        </item>
        <item>
            <title>Cefuroxime axetil: Anaphylaxis with Kounis syndrome: case report</title>
            <link>http://www.medworm.com/index.php?rid=3256243&amp;cid=c_8_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001287%2Fart00038</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3256243</comments>
            <pubDate>Wed, 10 Feb 2010 14:08:42 +0100</pubDate>
            <guid isPermaLink="false">3256243</guid>        </item>
        <item>
            <title>Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery: Ten-year comparative study</title>
            <link>http://www.medworm.com/index.php?rid=3237814&amp;cid=c_8_30_f&amp;fid=38496&amp;url=http%3A%2F%2Fwww.jcrsjournal.org%2Farticle%2FPIIS0886335009009912%2Fabstract%3Frss%3Dyes</link>
            <description>Purpose: To determine the differences in the endophthalmitis rates in cataract surgery before and after prophylactic use of intracameral cefuroxime.Setting: University Hospital Fundación Alcorcón, Madrid, Spain.Methods: This prospective study evaluated patients who had cataract surgery at a university eye center over a 10-year period (1999 to 2008). Since the protocol's approval by the Hospital Board in October 2005 to the end of the 10-year period, cataract patients were routinely treated with prophylactic intracameral cefuroxime. A database was used to measure the occurrence of endophthalmitis postoperatively. Then, the incidence of endophthalmitis before and after generalized use of prophylactic cefuroxime was compared. The effect of cefuroxime was evaluated by the relative risk.Resul...</description>
            <author>Journal of Cataract and Refractive Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3237814</comments>
            <pubDate>Mon, 01 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3237814</guid>        </item>
        <item>
            <title>Assessing the accuracy of intracameral antibiotic preparation for use in cataract surgery</title>
            <link>http://www.medworm.com/index.php?rid=3237828&amp;cid=c_8_30_f&amp;fid=38496&amp;url=http%3A%2F%2Fwww.jcrsjournal.org%2Farticle%2FPIIS0886335009010487%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This study shows that the mathematical accuracy of a dilution protocol does not ensure dosage accuracy in the clinical scenario. Inadequate mixing in a 1.0 mL syringe was probably responsible for the inaccuracy of protocol 2, indicating that small-volume syringes should not be used for mixing. However, protocol 1 had an acceptable range of variability. Replication of this study could evaluate other protocols and address concerns regarding the accuracy of intracameral antibiotic preparations.Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned. (Source: Journal of Cataract and Refractive Surgery)</description>
            <author>Journal of Cataract and Refractive Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3237828</comments>
            <pubDate>Mon, 01 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3237828</guid>        </item>
        <item>
            <title>Med Sci Monit 2010; 16(2):CR84-91 &amp;quot;Bacterial colonization of pleural drains in patients with lung cancer: An analysis of risk factors&amp;quot;</title>
            <link>http://www.medworm.com/index.php?rid=3218989&amp;cid=c_8_39_f&amp;fid=36926&amp;url=http%3A%2F%2Fwww.medscimonit.com%2Fabstracted.php%3Ficid%3D878358%26level%3D5</link>
            <description>Conclusions:	Patients with resectable lung cancer showed a high rate of pleural drain colonization, mainly by opportunistic pathogens, even in the absence of clinical signs of infection. (Source: Medical Science Monitor)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medical Science Monitor</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218989</comments>
            <pubDate>Fri, 29 Jan 2010 15:18:37 +0100</pubDate>
            <guid isPermaLink="false">3218989</guid>        </item>
        <item>
            <title>CEFTIN (Cefuroxime Axetil) Powder, For Suspension CEFTIN (Cefuroxime Axetil) Tablet, Film Coated [GlaxoSmithKline LLC]</title>
            <link>http://www.medworm.com/index.php?rid=3218235&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D14969</link>
            <description>Updated Date: Jan 28, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218235</comments>
            <pubDate>Thu, 28 Jan 2010 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">3218235</guid>        </item>
        <item>
            <title>ZINACEF (Cefuroxime) Injection, Solution ZINACEF (Cefuroxime) Injection, Powder, Lyophilized, For Solution [GlaxoSmithKline LLC]</title>
            <link>http://www.medworm.com/index.php?rid=3218238&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D14972</link>
            <description>Updated Date: Jan 28, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218238</comments>
            <pubDate>Thu, 28 Jan 2010 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">3218238</guid>        </item>
        <item>
            <title>Cefuroxime axetil: Clostridium difficile diarrhoea in a child: case report</title>
            <link>http://www.medworm.com/index.php?rid=3209773&amp;cid=c_8_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001285%2Fart00035</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3209773</comments>
            <pubDate>Wed, 27 Jan 2010 14:05:47 +0100</pubDate>
            <guid isPermaLink="false">3209773</guid>        </item>
        <item>
            <title>Are cefuroxime and vancomycin really safe on the corneal endothelial cells?</title>
            <link>http://www.medworm.com/index.php?rid=3191439&amp;cid=c_8_30_f&amp;fid=33405&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5t2675247v2v14x8%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Corneal endothelial cells are very sensitive to any form of toxic exposure. Using intracameral cefuroxime during the anterior
 segment surgery may be more toxic on the endothelial tissue in patients with vulnerable corneal endothelium. Because of the
 definite risk of dosage errors, these agents should be prepared in the hospital pharmacy and not in the operating theatre.
 
 
 
	Content Type Journal ArticleCategory CorneaDOI 10.1007/s00417-009-1267-3Authors
		Tök Y. Özlem, Ankara Training and Research Hospital Department of Ophthalmology Ankara TurkeyDemir M. Necati, Ankara Training and Research Hospital Department of Ophthalmology Ankara TurkeyYilmaz M. Fatma, Ankara Training and Research Hospital Department of Biochemistry Ankara TurkeyYilmaz Gülsen, Ankara Trai...</description>
            <author>Graefe's Archive for Clinical and Experimental Ophthalmology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3191439</comments>
            <pubDate>Fri, 15 Jan 2010 00:42:27 +0100</pubDate>
            <guid isPermaLink="false">3191439</guid>        </item>
        <item>
            <title>Emerging &amp;lt;i&amp;gt;Salmonella&amp;lt;/i&amp;gt; Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla</title>
            <link>http://www.medworm.com/index.php?rid=3145618&amp;cid=c_8_77_f&amp;fid=33833&amp;url=http%3A%2F%2Fwww.ijmm.org%2Farticle.asp%3Fissn%3D0255-0857%3Byear%3D2010%3Bvolume%3D28%3Bissue%3D1%3Bspage%3D51%3Bepage%3D53%3Baulast%3DVerma</link>
            <description>Verma S, Thakur S, Kanga A, Singh G, Gupta PIndian Journal of Medical Microbiology 2010 28(1):51-53This retrospective study incorporates a six years, six months (January 2000-June 2006) laboratory data comprising 258 isolates of Salmonella. Cultures were identified by standard methods. &amp;#x0026;lt;i&amp;#x0026;gt;Salmonella&amp;#x0026;lt;/i&amp;#x0026;gt; &amp;#x0026;lt;i&amp;#x0026;gt;enterica&amp;#x0026;lt;/i&amp;#x0026;gt; serotype Typhi (&amp;#x0026;lt;i&amp;#x0026;gt;S&amp;#x0026;lt;/i&amp;#x0026;gt;.Typhi) was the more frequent serotype isolated i.e., 61.62&amp;#x0025; with the remaining 38.37&amp;#x0025; being &amp;#x0026;lt;i&amp;#x0026;gt;Salmonella&amp;#x0026;lt;/i&amp;#x0026;gt; &amp;#x0026;lt;i&amp;#x0026;gt;enterica&amp;#x0026;lt;/i&amp;#x0026;gt; serotype Paratyphi A (&amp;#x0026;lt;i&amp;#x0026;gt;S&amp;#x0026;lt;/i&amp;#x0026;gt;. Paratyphi A). There was emergence of &amp;#x00...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Indian Journal of Medical Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3145618</comments>
            <pubDate>Wed, 06 Jan 2010 16:14:05 +0100</pubDate>
            <guid isPermaLink="false">3145618</guid>        </item>
        <item>
            <title>Are local clinical guidelines useful in promoting rational use of antibiotic prophylaxis in Caesarean delivery?</title>
            <link>http://www.medworm.com/index.php?rid=3130966&amp;cid=c_8_13_f&amp;fid=36006&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkwv1q5214802278g%2F</link>
            <description>Conclusion In an attempt to ensure cost-effective prophylactic use of antibiotics in Caesarean delivery, local clinical guidelines were
 introduced. They resulted in changes in prescribing patterns of antibiotics. There was a significant decrease in use of ‘third’
 generation of cephalosporin’s whereas the use of “older” antibiotics with proven efficacy and safety increased. In contrast,
 there was no significant change in treatment outcomes such as wound infection and average hospital stay.
 
	Content Type Journal ArticleCategory Research ArticleDOI 10.1007/s11096-009-9359-zAuthors
		Svetlana Ristić, University of Belgrade Clinic of Gynaecology and Obstetrics “Narodni front”, Medical School Belgrade SerbiaBranislava Miljković, University of Belgrade Department of Pharmacok...</description>
            <author>Pharmacy World &amp; Science</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3130966</comments>
            <pubDate>Tue, 29 Dec 2009 06:56:47 +0100</pubDate>
            <guid isPermaLink="false">3130966</guid>        </item>
        <item>
            <title>Subjective Symptoms after Treatment of Early Lyme Disease</title>
            <link>http://www.medworm.com/index.php?rid=3119771&amp;cid=c_8_22_f&amp;fid=34384&amp;url=http%3A%2F%2Fwww.amjmed.com%2Farticle%2FPIIS0002934309005026%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: No significant differences were identified between doxycycline and cefuroxime axetil in the treatment of European patients with erythema migrans. The frequency of nonspecific symptoms in patients did not exceed that of a control group at ≥6 months after enrollment. We advocate inclusion of appropriate non-Lyme disease control groups in future studies in which nonspecific subjective symptoms are assessed after antibiotic therapy. (Source: The American Journal of Medicine)</description>
            <author>The American Journal of Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3119771</comments>
            <pubDate>Fri, 25 Dec 2009 14:25:15 +0100</pubDate>
            <guid isPermaLink="false">3119771</guid>        </item>
        <item>
            <title>CEFTIN (Cefuroxime Axetil) Powder, For Suspension CEFTIN (Cefuroxime Axetil) Tablet, Film Coated [GlaxoSmithKline LLC]</title>
            <link>http://www.medworm.com/index.php?rid=3086324&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D13473</link>
            <description>Updated Date: Dec 14, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3086324</comments>
            <pubDate>Mon, 14 Dec 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">3086324</guid>        </item>
        <item>
            <title>Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases</title>
            <link>http://www.medworm.com/index.php?rid=3087280&amp;cid=c_8_30_f&amp;fid=33405&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm4040p14603u2132%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;We present our experience from managing presumed bacterial endophthalmitis with 25&amp;nbsp;g PPV in patients previously implanted
 with Boston Kpro, which to the best of our knowledge has not been reported before. Although the number of cases is small to
 draw accurate conclusions, we have to report that 25&amp;nbsp;g vitrectomy was performed without significant difficulties and seems
 to be a useful tool for the management of patients with Kpros requiring vitreoretinal surgery.
 
 
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s00417-009-1230-3Authors
		Ilias Georgalas, University of Athens Department of Ophthalmology, “G.Gennimatas” Hospital Athens GreeceAnastasios J. Kanelopoulos, Laser vision Institute Athens GreecePetros Petrou, University of Athens...</description>
            <author>Graefe's Archive for Clinical and Experimental Ophthalmology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3087280</comments>
            <pubDate>Sat, 12 Dec 2009 14:16:42 +0100</pubDate>
            <guid isPermaLink="false">3087280</guid>        </item>
        <item>
            <title>The occurrence of antimicrobial resistance and class 1 integrons among commensal Escherichia coli isolates from infants and elderly persons</title>
            <link>http://www.medworm.com/index.php?rid=3064889&amp;cid=c_8_22_f&amp;fid=30439&amp;url=http%3A%2F%2Fwww.ann-clinmicrob.com%2Fcontent%2F8%2F1%2F34</link>
            <description>Background:
The aim of our study was to compare the presence of the intI1 gene and its associations with the antibiotic resistance of commensal Escherichia coli strains in children with/without previous antibiotic treatments and elderly hospitalized/healthy individuals.
Methods:
One-hundred-and-fifteen intestinal E. coli strains were analyzed: 30 strains from 10 antibiotic-naive infants; 27 from 9 antibiotic-treated outpatient infants; 30 from 9 healthy elderly volunteers; and 28 from 9 hospitalized elderly patients. The MIC values of ampicillin, cefuroxime, cefotaxime, gentamicin, ciprofloxacin, and sulfamethoxazole were measured by E-test and IntI1 was detected by PCR.
Results:
Out of the 115 strains, 56 (49%) carried class 1 integron genes. Comparing persons without medical intervention...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>BioMed Central</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3064889</comments>
            <pubDate>Tue, 08 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3064889</guid>        </item>
        <item>
            <title>Effect of cefuroxime and moxifloxacin on Staphylococcus epidermidis adherence to intraocular lenses.</title>
            <link>http://www.medworm.com/index.php?rid=3118009&amp;cid=c_8_30_f&amp;fid=37744&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20029484%26dopt%3DAbstract</link>
            <description>Conclusion: Our results suggest that moxifloxacin and cefuroxime significantly inhibit bacterial adherence to IOLs. The effect of moxifloxacin on inhibition of bacterial adherence was significantly greater than that of cefuroxime. For this reason moxifloxacin might be considered as a better prophylactic agent.
    PMID: 20029484 [PubMed - in process] (Source: Canadian Journal of Ophthalmology)</description>
            <author>Canadian Journal of Ophthalmology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3118009</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3118009</guid>        </item>
        <item>
            <title>Evidence-based adjustment of antibiotic in pediatric complicated appendicitis in the era of antibiotic resistance</title>
            <link>http://www.medworm.com/index.php?rid=3011130&amp;cid=c_8_43_f&amp;fid=33306&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe4803147117433t6%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;One-fourth of children with gangrenous or ruptured appendicitis were insensitive to the current regime. This study provides
 evidence-based information on the choice of antibiotics.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00383-009-2540-6Authors
		Kin Wai Edwin Chan, The Chinese University of Hong Kong, Prince of Wales Hospital Division of Paediatric Surgery and Paediatric Urology, Department of Surgery Hong Kong SAR ChinaKim Hung Lee, The Chinese University of Hong Kong, Prince of Wales Hospital Division of Paediatric Surgery and Paediatric Urology, Department of Surgery Hong Kong SAR ChinaJennifer Wai Cheung Mou, The Chinese University of Hong Kong, Prince of Wales Hospital Division of Paediatric Surgery and Paediatric Urology, Depa...</description>
            <author>Pediatric Surgery International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3011130</comments>
            <pubDate>Wed, 18 Nov 2009 00:07:27 +0100</pubDate>
            <guid isPermaLink="false">3011130</guid>        </item>
        <item>
            <title>Impact of a Change in Antibiotic Prophylaxis on Total Antibiotic Use in a Surgical Intensive Care Unit</title>
            <link>http://www.medworm.com/index.php?rid=2986780&amp;cid=c_8_20_f&amp;fid=33374&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj28250v3x2u7446l%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Change to single shot prophylaxis along with an ongoing antibiotic stewardship program resulted in a cut-back in total antibiotic
 use amounting to as much as 15%. It would therefore appear that targeting interventions aimed at reducing antibiotic prophylaxis
 in surgical ICUs may be very worthwhile.
 
 
 
	Content Type Journal ArticleCategory Clinical and Epidemiological StudyDOI 10.1007/s15010-009-9115-2Authors
		E. Meyer, Charité University Medicine Institute of Hygiene and Environmental Medicine Hindenburgdamm 27 12203 Berlin GermanyF. Schwab, Charité University Medicine Institute of Hygiene and Environmental Medicine Hindenburgdamm 27 12203 Berlin GermanyA. Pollitt, Klinikum Stuttgart, Katharinenhospital Institute of Hospital Hygiene Stuttgart GermanyW. Bettolo...</description>
            <author>Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2986780</comments>
            <pubDate>Wed, 11 Nov 2009 06:57:25 +0100</pubDate>
            <guid isPermaLink="false">2986780</guid>        </item>
        <item>
            <title>Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment</title>
            <link>http://www.medworm.com/index.php?rid=3058095&amp;cid=c_8_13_f&amp;fid=35634&amp;url=http%3A%2F%2Fwww.ijaaonline.com%2Farticle%2FPIIS0924857909004166%2Fabstract%3Frss%3Dyes</link>
            <description>In conclusion, increased co-trimoxazole non-susceptibility rates undermine its use as a first-line agent in empirical treatment, especially in cases of recent use of co-trimoxazole and/or amoxicillin. Fluoroquinolones display potent in vitro activity against community uropathogens, but prudent use is warranted for uncomplicated infections. Mecillinam and nitrofurantoin could serve as effective front-line agents in an effort to design fluoroquinolones-sparing regimens. (Source: International Journal of Antimicrobial Agents)</description>
            <author>International Journal of Antimicrobial Agents</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3058095</comments>
            <pubDate>Wed, 11 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3058095</guid>        </item>
        <item>
            <title>Effect of Periarticular Corticosteroid Injections During Total Knee Arthroplasty. A Double-Blind Randomized Trial</title>
            <link>http://www.medworm.com/index.php?rid=2952869&amp;cid=c_8_31_f&amp;fid=29528&amp;url=http%3A%2F%2Fwww.ejbjs.org%2Fcgi%2Fcontent%2Fshort%2F91%2F11%2F2550%3Frss%3D1</link>
            <description>Conclusions: The periarticular injection of a corticosteroid may reduce the length of the hospital stay following total knee arthroplasty, but it does not appear to improve pain relief, motion, or function in the early postoperative period. While we cannot definitively state that the corticosteroid was a causative factor in the development of the infection at the site of the prosthetic joint, we cannot rule it out either, which raises concern regarding the role of corticosteroids in perioperative pain management following total knee arthroplasty.
Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence. (Source: JBJS [Am])&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>JBJS [Am]</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2952869</comments>
            <pubDate>Mon, 02 Nov 2009 18:02:22 +0100</pubDate>
            <guid isPermaLink="false">2952869</guid>        </item>
        <item>
            <title>ZINACEF (Cefuroxime) Injection, Solution ZINACEF (Cefuroxime) Injection, Powder, Lyophilized, For Solution [SmithKline Beecham Corporation]</title>
            <link>http://www.medworm.com/index.php?rid=2952014&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D12341</link>
            <description>Updated Date: Nov 2, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2952014</comments>
            <pubDate>Mon, 02 Nov 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2952014</guid>        </item>
        <item>
            <title>Molecular and biochemical characterization of the natural chromosome-encoded class A {beta}-lactamase from Pseudomonas luteola.</title>
            <link>http://www.medworm.com/index.php?rid=2960178&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19884377%26dopt%3DAbstract</link>
            <description>Authors: Doublet B, Robin F, Casin I, Fabre L, Le Fleche A, Bonnet R, Weill FX
    Pseudomonas luteola (formerly classified as CDC group Ve-1 and named Chryseomonas luteola) is an unusual pathogen implicated in rare but serious infections in humans. A novel beta-lactamase gene, blaLUT-1 was cloned from the whole-cell DNA of the P. luteola clinical isolate LAM, which had a weak narrow-spectrum beta-lactam-resistant phenotype, and expressed in Escherichia coli. This gene encoded LUT-1, a 296-amino acid Ambler class A beta-lactamase with a pI value of 6 and a theoretical molecular mass of 28.9 kD. The catalytic efficiency of this enzyme was higher for cephalothin, cefuroxime, and cefotaxime than for penicillins. It was found to be 49 % to 59 % identical to other Ambler class A beta-lactamases...</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2960178</comments>
            <pubDate>Mon, 02 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2960178</guid>        </item>
        <item>
            <title>Antimicrobial Resistance in Haemophilus influenzae Respiratory Tract Isolates in Korea: Results of the Nationwide Acute Respiratory Infections Surveillance.</title>
            <link>http://www.medworm.com/index.php?rid=2960189&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19884366%26dopt%3DAbstract</link>
            <description>Authors: Bae S, Lee J, Lee J, Kim E, Lee S, Yu J, Kang Y
    Antimicrobial susceptibility patterns and beta-lactam resistance mechanisms of 544 H. influenzae isolates through the nationwide Acute Respiratory Infections Surveillance (ARIS) network in Korea during 2005 and 2006 were determined. Resistance to ampicillin was 58.5%, followed by cefuroxime (23.3%), clarithromycin (18.7%), cefaclor (17.0%), amoxicillin/clavulanate (10.4%), and chloramphenicol (8.1%). Levofloxacin and cefotaxime were the most active agents tested in this study. beta-lactamase production (52.4%) was the main mechanism of ampicillin resistance, with the rate (96.1%) of TEM-1 type beta-lactamase. According to their beta-lactam resistance mechanisms, all isolates were classified into the following groups: beta-lactama...</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2960189</comments>
            <pubDate>Mon, 02 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2960189</guid>        </item>
        <item>
            <title>Effect of periarticular corticosteroid injections during total knee arthroplasty. A double-blind randomized trial.</title>
            <link>http://www.medworm.com/index.php?rid=2964152&amp;cid=c_8_31_f&amp;fid=37684&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19884426%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The periarticular injection of a corticosteroid may reduce the length of the hospital stay following total knee arthroplasty, but it does not appear to improve pain relief, motion, or function in the early postoperative period. While we cannot definitively state that the corticosteroid was a causative factor in the development of the infection at the site of the prosthetic joint, we cannot rule it out either, which raises concern regarding the role of corticosteroids in perioperative pain management following total knee arthroplasty.
    PMID: 19884426 [PubMed - in process] (Source: The Journal of Bone and Joint Surgery. American volume)</description>
            <author>The Journal of Bone and Joint Surgery. American volume</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2964152</comments>
            <pubDate>Sun, 01 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2964152</guid>        </item>
        <item>
            <title>An Outbreak of Early-Onset Endophthalmitis Caused by Fusarium Species following Cataract Surgery.</title>
            <link>http://www.medworm.com/index.php?rid=3060293&amp;cid=c_8_30_f&amp;fid=32275&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19958115%26dopt%3DAbstract</link>
            <description>Conclusion: Fusarium should be considered in the differential diagnosis of early-onset endophthalmitis after cataract surgery. An aggressive treatment with local and systemic antifungal agents and multiple vitrectomies with silicone oil injection is helpful in the management of postoperative early-onset Fusarium endophthalmitis. In the prevention of such outbreaks, it is important to use solutions prepared differently for each patient.
    PMID: 19958115 [PubMed - as supplied by publisher] (Source: Current Eye Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Current Eye Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3060293</comments>
            <pubDate>Sun, 01 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3060293</guid>        </item>
        <item>
            <title>Cefuroxime dilution error.</title>
            <link>http://www.medworm.com/index.php?rid=2963986&amp;cid=c_8_30_f&amp;fid=37927&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19882526%26dopt%3DAbstract</link>
            <description>Conclusions. Inadvertent intracameral (3 mg in 0.1 mL) cefuroxime injection did not cause any detectable adverse effect on ocular tissues.
    PMID: 19882526 [PubMed - as supplied by publisher] (Source: European Journal of Ophthalmology)</description>
            <author>European Journal of Ophthalmology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2963986</comments>
            <pubDate>Tue, 27 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2963986</guid>        </item>
        <item>
            <title>Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study</title>
            <link>http://www.medworm.com/index.php?rid=2921864&amp;cid=c_8_22_f&amp;fid=30439&amp;url=http%3A%2F%2Fwww.ann-clinmicrob.com%2Fcontent%2F8%2F1%2F27</link>
            <description>Background:
The aims of this study were to determine the antimicrobial susceptibility patterns of urinary isolates from community acquired acute uncomplicated urinary tract infections (uUTI) and to evaluate which antibiotics were empirically prescribed in the outpatient management of uUTI.
Methods:
Among the patients which were admitted to outpatient clinics of Ankara University Medical Faculty, Ibni-Sina Hospital during 2005-2006, a total of 429 women between the age of 18 and 65 years old who were clinically diagnosed with uUTI and to whom prescribed empirical antibiotics were enrolled in this prospective observational study. Patients' demographical data, urine culture results, resistance rates to antimicrobial agents and prescribed empiric antimicrobial therapy were analyzed.
Results:
T...</description>
            <author>BioMed Central</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2921864</comments>
            <pubDate>Fri, 23 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2921864</guid>        </item>
        <item>
            <title>Clinical research The effect of treatment on lipid peroxidation in patients with subarachnoid haemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=2918079&amp;cid=c_8_22_f&amp;fid=30447&amp;url=http%3A%2F%2Fwww.termedia.pl%2Fmagazine.php%3Fmagazine_id%3D19%26article_id%3D13459%26magazine_subpage%3DFULL_TEXT%26language%3DEN</link>
            <description>Conclusions: Surgical and pharmacological treatment of SAH patients restored prooxidant-antioxidant balance. Evaluation of TBARS and CD level, in SAH patients&amp;#8217; peripheral blood may help to monitor the therapy efficiency in normalization of CNS oxygen metabolism. (Source: Articles of Archives of Medical Science - TERMEDIA publishing house)</description>
            <author>Articles of Archives of Medical Science - TERMEDIA publishing house</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918079</comments>
            <pubDate>Thu, 22 Oct 2009 13:36:31 +0100</pubDate>
            <guid isPermaLink="false">2918079</guid>        </item>
        <item>
            <title>Med Sci Monit 2009; 15(11):PI61-65 &amp;quot;Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey&amp;quot;</title>
            <link>http://www.medworm.com/index.php?rid=2904064&amp;cid=c_8_39_f&amp;fid=36926&amp;url=http%3A%2F%2Fwww.medscimonit.com%2Fabstracted.php%3Ficid%3D878224%26level%3D5</link>
            <description>Conclusions:	The most important finding of our study is that a considerable proportion of the studied E. coli isolates were resistant to most antibiotics except amikacin. These data provide useful information for clinicians in determining the appropriate empirical antimicrobial regimen, and help authorities to formulate antibiotic prescription policies. (Source: Medical Science Monitor)</description>
            <author>Medical Science Monitor</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2904064</comments>
            <pubDate>Mon, 19 Oct 2009 11:44:00 +0100</pubDate>
            <guid isPermaLink="false">2904064</guid>        </item>
        <item>
            <title>Rare extraintestinal infection caused by toxin-producing Clostridium difficile.</title>
            <link>http://www.medworm.com/index.php?rid=2912739&amp;cid=c_8_77_f&amp;fid=34508&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19835967%26dopt%3DAbstract</link>
            <description>We report here on rare extraintestinal infection caused by toxigenic C. difficile: 31-year-old male, accident victim was admitted to the hospital because of polytrauma. Microbiological examination of the pus revealed a toxin-producing C. difficile as an etiologic factor of this infection. Empiric antibiotic treatment with cefuroxime had been administered right after the positive microbiological result. On the basis of antibiotic susceptibility testing, the isolated strain was susceptible to most antimicrobials, except from cefoxitin, thus cefuroxime was changed to imipenem.
    PMID: 19835967 [PubMed - as supplied by publisher] (Source: Anaerobe)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Anaerobe</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2912739</comments>
            <pubDate>Mon, 12 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2912739</guid>        </item>
        <item>
            <title>Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=2877788&amp;cid=c_8_20_f&amp;fid=38905&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDisease-Focused-Reviews%2FAntibacterial-class-is-not-obviously-important-in-outpatient-pneumonia-a-meta-analysis%2F</link>
            <description>Source: DARE
Area: Evidence &gt; Disease Focused Reviews
 CRD Summary: This review assessed whether improved clinical and mortality outcomes are achieved for outpatient community acquired pneumonia treated with antibacterials with coverage against atypical organisms. The authors concluded that there was no evidence of superiority for any drug comparison. Given some methodological uncertainties identified in the review process, the extent to which this conclusion was reliable was unclear. 
 [The included studies assessed the following oral therapies at differing doses: fluoroquinolones (moxifloxacin, sparfloxacin, levofloxacin, grepafloxacin, trovafloxacin); macrolides (clarithromycin, azithromycin, roxithromycin); cephalosporins (cefaclor, cefixime, ceftidoren, cefuroxime); and penicillin (am...</description>
            <author>NeLM - Infectious Diseases</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2877788</comments>
            <pubDate>Thu, 08 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2877788</guid>        </item>
        <item>
            <title>Implant orthopaedic surgery in HIV asymptomatic carriers: Management and early outcome</title>
            <link>http://www.medworm.com/index.php?rid=2860701&amp;cid=c_8_31_f&amp;fid=35629&amp;url=http%3A%2F%2Fwww.injuryjournal.com%2Farticle%2FPIIS0020138308005731%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The authors conclude that if a prolonged prophylactic antibiotic therapy and systematic antiretroviral therapy are given to HIV immune-depressed carriers undergoing implant orthopaedic surgery, their post-operative infection risk may be close to that of non-HIV carriers. (Source: Injury)</description>
            <author>Injury</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2860701</comments>
            <pubDate>Mon, 05 Oct 2009 17:19:10 +0100</pubDate>
            <guid isPermaLink="false">2860701</guid>        </item>
        <item>
            <title>Anti-inflammatory effects of antibacterials on human bronchial epithelial cells</title>
            <link>http://www.medworm.com/index.php?rid=2840418&amp;cid=c_8_22_f&amp;fid=30439&amp;url=http%3A%2F%2Frespiratory-research.com%2Fcontent%2F10%2F1%2F89</link>
            <description>Background:
Human Bronchial epithelial cells (hu-BEC) have been claimed to play a significant role in the pathogenesis of chronic inflammatory airway diseases like COPD. In this context IL-8 and GM-CSF have been shown to be key cytokines. Some antibiotics which are routinely used to treat lower respiratory tract infections have been shown to exert additional immunomodulatory or anti-inflammatory effects. We investigated whether these effects can also be detected in hu-BEC.
Methods:
Hu-BEC obtained from patients undergoing lung resections were transferred to air-liquid-interface (ALI) culture. These cultures were incubated with cefuroxime (CXM, 10-62.5 mg/l), azithromycin (AZM, 0.1-1.5 mg/l), levofloxacin (LVX, 1-8 mg/l) and moxifloxacin (MXF, 1-16 mg/l). The spontaneous and TNF-alpha (10 n...</description>
            <author>BioMed Central</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2840418</comments>
            <pubDate>Mon, 28 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2840418</guid>        </item>
        <item>
            <title>Reply: Cataract surgery in infant eyes with microphthalmos</title>
            <link>http://www.medworm.com/index.php?rid=2826660&amp;cid=c_8_30_f&amp;fid=38496&amp;url=http%3A%2F%2Fwww.jcrsjournal.org%2Farticle%2FPIIS0886335009006749%2Fabstract%3Frss%3Dyes</link>
            <description>Khokhar and Dave express concern about the efficacy and safety of intracameral vancomycin in pediatric eyes in which PCCC and anterior vitrectomy have been performed. In the ESCRS endophthalmitis study, the use of intracameral cefuroxime in adults reduced the risk for endophthalmitis. Intracameral vancomycin has been safely and effectively used in adults for endophthalmitis prophylaxis. We believe it will be equally effective in pediatric eyes. In our series, we patched the child's eye for 2 hours only, following which the patch was removed and antibiotic eyedrops were started. Therefore, by the time anterior chamber clearing was complete, the child had started on topical antibiotic agents. (Source: Journal of Cataract and Refractive Surgery)</description>
            <author>Journal of Cataract and Refractive Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2826660</comments>
            <pubDate>Thu, 24 Sep 2009 17:02:21 +0100</pubDate>
            <guid isPermaLink="false">2826660</guid>        </item>
        <item>
            <title>Cefuroxime axetil/dextromethorphan/paracetamol/pseudoephedrine: Arrhythmias and shock: case report</title>
            <link>http://www.medworm.com/index.php?rid=2813252&amp;cid=c_8_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2009%2F00000001%2F00001270%2Fart00028</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2813252</comments>
            <pubDate>Mon, 21 Sep 2009 16:25:31 +0100</pubDate>
            <guid isPermaLink="false">2813252</guid>        </item>
        <item>
            <title>Cefuroxime: Pemphigus erythematous: case report</title>
            <link>http://www.medworm.com/index.php?rid=2813253&amp;cid=c_8_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2009%2F00000001%2F00001270%2Fart00029</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2813253</comments>
            <pubDate>Mon, 21 Sep 2009 16:25:31 +0100</pubDate>
            <guid isPermaLink="false">2813253</guid>        </item>
        <item>
            <title>Characterization of a New Metallo-{beta}-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.</title>
            <link>http://www.medworm.com/index.php?rid=2824627&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19770275%26dopt%3DAbstract</link>
            <description>Authors: Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR
    A Swedish patient of Indian origin travelled to New Delhi and acquired a UTI caused by a carbapenem resistant Klebsiella pneumoniae typing to complex ST14. The isolate, K. pneumoniae 05-506, was shown to possess a metallo-beta-lactamase (MBLs) but was negative for previously known MBL genes. Gene libraries and amplification of class 1 integrons revealed three resistant regions; the first, contained blaCMY-4 flanked by ISEcP1 and blc. The second region of 4.8 kb contained a complex class 1 integron with the gene cassettes, arr-2, a new erythromycin esterase gene, ereC, aadA1 and cmlA7. An intact ISCR1 was shown to be downstream from the qac/sul genes. The third region consisted of a new MBL gene, designated blaNDM...</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2824627</comments>
            <pubDate>Sun, 20 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2824627</guid>        </item>
        <item>
            <title>In&amp;nbsp;vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993&amp;#x2013;2007 in Sweden</title>
            <link>http://www.medworm.com/index.php?rid=3346205&amp;cid=c_8_77_f&amp;fid=33107&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1469-0691.2009.03048.x</link>
            <description>This study investigated the MICs of 17 antimicrobials, for 606 toxigenic clinical isolates of Clostridium difficile collected between 1993 and 2007 in Sweden. Low MIC90 values were found for metronidazole (0.5 mg/L), vancomycin (1.0 mg/L), teicoplanin (0.125 mg/L), fusidic acid (1.0 mg/L), linezolid (2.0 mg/L), daptomycin (2.0 mg/L) and tigecycline (0.064 mg/L). Three isolates (0.5%) had elevated MICs for vancomycin (4[ndash]8 mg/L); however, these isolates originated from the same patient, who was receiving long-term intravenous vancomycin treatment. High-level clindamycin resistant isolates (MIC &gt;256 mg/L) peaked in 1997 with 39 of 95 (41%) and out of these, 36% were also highly resistant to erythromycin. [beta]-Lactams such as penicillin V and piperacillin displayed MIC90s of 8 and 32 m...</description>
            <author>Clinical Microbiology and Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3346205</comments>
            <pubDate>Thu, 03 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3346205</guid>        </item>
        <item>
            <title>Bacteriological profile and antimicrobial resistance patterns of clinical bacterial isolates in a University Hospital</title>
            <link>http://www.medworm.com/index.php?rid=2754526&amp;cid=c_8_20_f&amp;fid=36132&amp;url=http%3A%2F%2Fwww.travelmedicinejournal.com%2Farticle%2FPIIS1477893909001239%2Fabstract%3Frss%3Dyes</link>
            <description>The objective of this study was to determine the patterns of bacterial isolates found in blood culture of patients with bactermia in King Abdul Aziz University Hospital in addition to determination of antibiotic resistance. A retrospective analysis of the 672 positive samples collected over the period of December 2006–December 2008. The observed mean age was 40 years with comparable distribution in both genders. 65.2% of the population were Non-Saudi. 65.5% of isolates were Gram positive, mainly Staphylococcus epidermidis, on the other hand Klebsiella was the common Gram negative bacteria. Diabetes has been observed in 38.5%. Mortality was 32.4 (P-value 0.001) in diabetic patients versus non-diabetics. Benzyl penicillin, clindamycin, erythromycin, tetracycline, ciprofloxacin, oxacillin c...</description>
            <author>Travel Medicine and Infectious Disease</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2754526</comments>
            <pubDate>Mon, 24 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2754526</guid>        </item>
        <item>
            <title>Endophthalmitis following cataract surgery: The sucking corneal wound</title>
            <link>http://www.medworm.com/index.php?rid=2707025&amp;cid=c_8_30_f&amp;fid=38496&amp;url=http%3A%2F%2Fwww.jcrsjournal.org%2Farticle%2FPIIS0886335009005653%2Fabstract%3Frss%3Dyes</link>
            <description>We were quite surprised, and also concerned, to note that a patient given the proposed Northern European panacea for prevention of endophthalmitis following cataract surgery (that is, intracameral cefuroxime) developed bilateral postoperative endophthalmitis. This occurred 4 days after bilateral cataract surgery performed at the same sitting. (Source: Journal of Cataract and Refractive Surgery)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Cataract and Refractive Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2707025</comments>
            <pubDate>Tue, 18 Aug 2009 10:50:39 +0100</pubDate>
            <guid isPermaLink="false">2707025</guid>        </item>
        <item>
            <title>Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery</title>
            <link>http://www.medworm.com/index.php?rid=2707004&amp;cid=c_8_30_f&amp;fid=38496&amp;url=http%3A%2F%2Fwww.jcrsjournal.org%2Farticle%2FPIIS0886335009005070%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Swollen lids, pain, and an opaque vitreous were statistically associated with proven endophthalmitis cases in the ESCRS study. (Source: Journal of Cataract and Refractive Surgery)</description>
            <author>Journal of Cataract and Refractive Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2707004</comments>
            <pubDate>Tue, 18 Aug 2009 10:50:32 +0100</pubDate>
            <guid isPermaLink="false">2707004</guid>        </item>
        <item>
            <title>Streptococcus pneumoniae Serotype 3 among Costa Rican Children with Otitis Media: clinical, epidemiological characteristics and antimicrobial resistance patterns</title>
            <link>http://www.medworm.com/index.php?rid=2701235&amp;cid=c_8_33_f&amp;fid=34043&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1471-2431%2F9%2F52</link>
            <description>Conclusion:
Streptococcus pneumoniae serotype 3 is an important pathogen in Costa Rican children with otitis media, especially in children older than 24 months of age (P=0.05). Most serotype 3 isolates were susceptible to penicillin, cephalosporins, macrolides and quinolones. (Source: BMC Pediatrics - Latest articles)</description>
            <author>BMC Pediatrics  - Latest articles</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2701235</comments>
            <pubDate>Thu, 13 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2701235</guid>        </item>
        <item>
            <title>Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria</title>
            <link>http://www.medworm.com/index.php?rid=2687099&amp;cid=c_8_40_f&amp;fid=33612&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fppul.21059</link>
            <description>No recent Austrian data are available on the epidemiology and morbidity of Chlamydophila pneumoniae (C. pneumoniae) as causative agent in youths and children hospitalized with community-acquired pneumonia (CAP). These data would serve as a rationale for empiric antimicrobial therapy.During winter months 2006/7 112 immunocompetent youths and children between 2 months and 18 years hospitalized consecutively with CAP were prospectively enrolled. Microbiological detection of conventional bacteria, Mycoplasma pneumoniae as well as respiratory viruses was performed, and clinical signs as well as indices of inflammation were documented. Diagnosis of C. pneumoniae was performed by means of species-specific real-time PCR as well as cell culture from respiratory secretions.PCR for C. pneumoniae was ...</description>
            <author>Pediatric Pulmonology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687099</comments>
            <pubDate>Sun, 09 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2687099</guid>        </item>
        <item>
            <title>Macrolide-Induced Digoxin Toxicity: A Population-Based Study.</title>
            <link>http://www.medworm.com/index.php?rid=2612013&amp;cid=c_8_13_f&amp;fid=34412&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19606089%26dopt%3DAbstract</link>
            <description>Authors: Gomes T, Mamdani MM, Juurlink DN
    In this 15-year, population-based, nested case-control study, we investigated the association between hospitalization for digoxin toxicity and recent exposure to individual macrolide antibiotics. Clarithromycin was associated with the highest risk of digoxin toxicity (adjusted odds ratio (OR) 14.8; 95% confidence interval (CI) 7.9-27.9), whereas erythromycin and azithromycin were associated with much lower risk (adjusted OR 3.7; 95% CI 1.7-7.9; and adjusted OR 3.7; 95% CI 1.1-12.5, respectively). We found no increased risk with a neutral comparator, cefuroxime (adjusted OR 0.8; 95% CI 0.2-3.4).Clinical Pharmacology &amp; Therapeutics (2009); advance online publication 15 July 2009. doi:10.1038/clpt.2009.127.
    PMID: 19606089 [PubMed - as supp...</description>
            <author>Clinical Pharmacology and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2612013</comments>
            <pubDate>Tue, 14 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2612013</guid>        </item>
        <item>
            <title>Quantification and prediction of skin pharmacokinetics of amoxicillin and cefuroxime</title>
            <link>http://www.medworm.com/index.php?rid=2589696&amp;cid=c_8_13_f&amp;fid=33588&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fbdd.658</link>
            <description>In conclusion, this study shows that it is possible to generate a reasonable prediction of skin pharmacokinetics from any plasma level once a careful characterization of the transfer process between plasma and skin has been made. Copyright © 2009 John Wiley &amp; Sons, Ltd. (Source: Biopharmaceutics and Drug Disposition)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Biopharmaceutics and Drug Disposition</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589696</comments>
            <pubDate>Fri, 10 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2589696</guid>        </item>
        <item>
            <title>Bacterial contamination of blood and blood components in three major blood transfusion centers, accra, ghana.</title>
            <link>http://www.medworm.com/index.php?rid=2638360&amp;cid=c_8_20_f&amp;fid=33089&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19628902%26dopt%3DAbstract</link>
            <description>This study was conducted to determine the prevalence of bacterial contamination of blood and its products at the three major blood transfusion centers in the Greater Accra Region of Ghana. Stored whole blood and its products were cultured on different media, and isolates were identified using standard biochemical and bacteriological methods. The susceptibility of the isolates to selected antimicrobial agents was also determined by the disc diffusion method. The overall prevalence rate was 9% (28/303; whole blood, 13% [24/192]; plasma, 3% [2/79]; platelet, 9% [2/22]). The Gram-positive bacteria isolated were coagulase-negative Staphylococcus, S. aureus, and Bacillus spp., and the Gram-negative organisms were Yersinia enterocolitica, Citrobacter freundii, Escherichia coli, Pseudomonas aerugi...</description>
            <author>Japanese Journal of Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2638360</comments>
            <pubDate>Tue, 30 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2638360</guid>        </item>
        <item>
            <title>Peritonsillar abscess in children in the southern district of Israel</title>
            <link>http://www.medworm.com/index.php?rid=2551151&amp;cid=c_8_16_f&amp;fid=38484&amp;url=http%3A%2F%2Fwww.ijporlonline.com%2Farticle%2FPIIS0165587609002353%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Peritonsillar abscess, a potentially life threatening infection, is similar in presentation and bacteriology in the pediatric and the adult population. Based on our review we conclude that peritonsillar abscess in children can be effectively treated by the same methods used in the adult population. (Source: International Journal of Pediatric Otorhinolaryngology)</description>
            <author>International Journal of Pediatric Otorhinolaryngology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2551151</comments>
            <pubDate>Mon, 29 Jun 2009 15:17:28 +0100</pubDate>
            <guid isPermaLink="false">2551151</guid>        </item>
        <item>
            <title>Prevalence and antibiotic susceptibility of thermophilic Campylobacter isolates from free range domestic duck (Cairina moschata) in Morogoro municipality, Tanzania</title>
            <link>http://www.medworm.com/index.php?rid=2560462&amp;cid=c_8_80_f&amp;fid=36010&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk27882jp9618j012%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Prevalence and antibiotic susceptibility of thermophilic Campylobacter isolated from free-ranging ducks was determined in Morogoro Municipality, Tanzania. Ninety intestinal contents from ducks
 were screened for thermophilic Campylobacter using Skirrow’s protocol. Of the Campylobacter jejuni isolates, 50 were tested for sensitivity to 12 antibiotics. Overall prevalence of thermophilic Campylobacter was 80%. The prevalence of Campylobacter in adult ducks (91.3%) was significantly (p &amp;lt; 0.05) higher than ducklings (68.2%). The isolation rate of C. jejuni (81.9%) was significantly (P &amp;lt; 0.001) higher than C. coli (18.1%). All C. jejuni isolates were susceptible to streptomycin, nitrofurantoin and amikacin. Forty eight percent, 74% and 82% of isolates were
 re...</description>
            <author>Tropical Animal Health and Production</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2560462</comments>
            <pubDate>Mon, 29 Jun 2009 08:22:29 +0100</pubDate>
            <guid isPermaLink="false">2560462</guid>        </item>
        <item>
            <title>Cost-Effectiveness Analysis of Intracameral Cefuroxime Use for Prophylaxis of Endophthalmitis after Cataract Surgery</title>
            <link>http://www.medworm.com/index.php?rid=2849000&amp;cid=c_8_30_f&amp;fid=36642&amp;url=http%3A%2F%2Fwww.ophsource.org%2Fperiodicals%2Fophtha%2Farticle%2FPIIS0161642009002784%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Administration of intracameral cefuroxime is relatively cost-effective in preventing endophthalmitis after cataract surgery. Owing to their high costs, many commonly used topical antibiotics are not cost-effective compared with intracameral cefuroxime, even under optimistic assumptions about their efficacy.Financial Disclosure(s): The authors have no proprietary or commercial interest in any of the materials discussed in this article. (Source: Ophthalmology)</description>
            <author>Ophthalmology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2849000</comments>
            <pubDate>Sun, 28 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2849000</guid>        </item>
        <item>
            <title>Immediate-type allergic reaction to cefuroxime: cross-reactivity with other cephalosporins, and good tolerance to ceftazidime.</title>
            <link>http://www.medworm.com/index.php?rid=2529790&amp;cid=c_8_3_f&amp;fid=33156&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19476025%26dopt%3DAbstract</link>
            <description>Authors: Varela Losada S, Gonz&amp;#xE1;lez de la Cuesta C, Alvarez-Eire MG, Gonz&amp;#xE1;lez Gonz&amp;#xE1;lez C
    
    PMID: 19476025 [PubMed - in process] (Source: Journal of Investigational Allergology &amp; Clinical Immunology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Investigational Allergology &amp; Clinical Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2529790</comments>
            <pubDate>Sat, 27 Jun 2009 13:48:04 +0100</pubDate>
            <guid isPermaLink="false">2529790</guid>        </item>
        <item>
            <title>A New Semi-Physiological Absorption Model to Assess the Pharmacodynamic Profile of Cefuroxime Axetil using Nonparametric and Parametric Population Pharmacokinetics.</title>
            <link>http://www.medworm.com/index.php?rid=2549288&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19528278%26dopt%3DAbstract</link>
            <description>Authors: Bulitta JB, Landersdorfer CB, Kinzig M, Holzgrabe U, Sorgel F
    Cefuroxime axetil is widely used to treat respiratory tract infections. We are not aware of a population pharmacokinetic (PK) model for cefuroxime axetil. Our objectives were to develop a semi-physiological population PK model and evaluate the pharmacodynamic (PD) profile for cefuroxime axetil. Twenty-four healthy volunteers received 250mg oral cefuroxime as suspension after a standardized breakfast. LC-MS/MS was used for drug analysis, NONMEM and S-ADAPT (results reported) for parametric population PK, and NPAG for nonparametric population PK modeling. Monte Carlo simulations were used to predict the time of non-protein bound concentration above the MIC (fT&amp;gt;MIC). A model with one disposition compartment, a satur...</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2549288</comments>
            <pubDate>Sun, 14 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2549288</guid>        </item>
        <item>
            <title>Cefuroxime: Drug hypersensitivity: case report</title>
            <link>http://www.medworm.com/index.php?rid=2465168&amp;cid=c_8_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2009%2F00000001%2F00001255%2Fart00032</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2465168</comments>
            <pubDate>Tue, 09 Jun 2009 16:41:07 +0100</pubDate>
            <guid isPermaLink="false">2465168</guid>        </item>
        <item>
            <title>The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections</title>
            <link>http://www.medworm.com/index.php?rid=2791401&amp;cid=c_8_13_f&amp;fid=35634&amp;url=http%3A%2F%2Fwww.ijaaonline.com%2Farticle%2FPIIS0924857909002143%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: The ARESC (Antimicrobial Resistance Epidemiological Survey on Cystitis) study is an international survey to investigate the prevalence and susceptibility of pathogens causing cystitis. Female patients (n=4264) aged 18–65 years with symptoms of uncomplicated cystitis were consecutively enrolled in nine European countries as well as Brazil during 2003–2006. Pathogens were identified and their susceptibility to nine antimicrobials was determined. Escherichia coli accounted for 76.7% of isolates. Among E. coli, 10.3% of the isolates were resistant to at last three different classes of antimicrobial agents. Resistance was most common to ampicillin (48.3%), trimethoprim/sulfamethoxazole (29.4%) and nalidixic acid (18.6%). Fosfomycin, mecillinam and nitrofurantoin were the most acti...</description>
            <author>International Journal of Antimicrobial Agents</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2791401</comments>
            <pubDate>Mon, 08 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2791401</guid>        </item>
        <item>
            <title>Cefuroxime: Drug hypersensitivity: case report.</title>
            <link>http://www.medworm.com/index.php?rid=2459739&amp;cid=c_8_13_f&amp;fid=34372&amp;url=http%3A%2F%2Freactions.adisonline.com%2Fpt%2Fre%2Frea%2Fabstract.00128415-200912550-00030.htm</link>
            <description>Page: 12 (Source: Reactions Weekly)</description>
            <author>Reactions Weekly</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2459739</comments>
            <pubDate>Sun, 07 Jun 2009 18:23:59 +0100</pubDate>
            <guid isPermaLink="false">2459739</guid>        </item>
        <item>
            <title>Evidence for Practice</title>
            <link>http://www.medworm.com/index.php?rid=2461088&amp;cid=c_8_27_f&amp;fid=34392&amp;url=http%3A%2F%2Fwww.aornjournal.org%2Farticle%2FPIIS0001209209003287%2Fabstract%3Frss%3Dyes</link>
            <description>Prophylactic regimens for endophthalmitis after cataract surgery include topical antibiotic drops and local antisepsis. However, there is increasing attention on the value of intracameral injection of antibiotics at the close of cataract surgery because this provides immediate, high, sustained antibiotic levels. Cefuroxime has been documented to be safe and effective when used via the intracameral route, and research continues on other antibiotic agents that may prove safe for intracameral injection as alternatives to address ongoing shifts in antimicrobial spectra and sensitivities. Fourth generation fluoroquinolones have been used in topical preoperative and postoperative antibiotic regimens for cataract surgery because of their broad spectrum of activity and overall safety. These agents...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>AORN Journal</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2461088</comments>
            <pubDate>Mon, 01 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2461088</guid>        </item>
        <item>
            <title>Characterization of two plasmid-encoded cefotaximases found in clinical Escherichia coli isolates: CTX-M-65 and a novel enzyme, CTX-M-87.</title>
            <link>http://www.medworm.com/index.php?rid=2473351&amp;cid=c_8_77_f&amp;fid=37692&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19429759%26dopt%3DAbstract</link>
            <description>Authors: Yin J, Cheng J, Sun Z, Ye Y, Gao YF, Li JB, Zhang XJ
    Three clinical strains of Escherichia coli (p168, p517 and p667) were collected in 2006 from three hospitals in Anhui Province (China). PCR and DNA sequencing revealed that E. coli p168 carried a novel extended-spectrum beta-lactamase (ESBL), which was designated CTX-M-87. The extended-spectrum beta-lactamase which was carried by E. coli p517 and E. coli p667 was previously named CTX-M-65. The deduced amino acid sequence of CTX-M-87, with pI 9.1, differed from that of CTX-M-14 by the substitutions Ala77--&amp;gt;Val and Pro167--&amp;gt;Leu. Like CTX-M-14, CTX-M-87 had a more potent hydrolytic activity against cefotaxime than against ceftazidime and had high affinity for cefuroxime and cefotaxime. These data show that mutations at po...</description>
            <author>Journal of Medical Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2473351</comments>
            <pubDate>Mon, 01 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2473351</guid>        </item>
        <item>
            <title>Interplay of Efflux, Impermeability, and AmpC Activity Contributes to Cefuroxime Resistance in Clinical, Non-ESBL-Producing Isolates of Escherichia coli</title>
            <link>http://www.medworm.com/index.php?rid=2414094&amp;cid=c_8_77_f&amp;fid=32566&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fmdr.2009.0883%3Fai%3Dsm%26mi%3Do0fy%26af%3DR</link>
            <description>Microbial Drug Resistance , Vol. 0, No. 0. (Source: Microbial Drug Resistance)</description>
            <author>Microbial Drug Resistance</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2414094</comments>
            <pubDate>Mon, 11 May 2009 15:25:42 +0100</pubDate>
            <guid isPermaLink="false">2414094</guid>        </item>
        <item>
            <title>Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method</title>
            <link>http://www.medworm.com/index.php?rid=2414148&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F63%2F6%2F1163%3Frss%3D1</link>
            <description>Conclusions
On the basis of our analysis, we expect that structure-based modification of the inhibitors can be employed to develop highly effective novel antibiotics against Lyme spirochaetes. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2414148</comments>
            <pubDate>Mon, 11 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2414148</guid>        </item>
        <item>
            <title>Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach</title>
            <link>http://www.medworm.com/index.php?rid=2414154&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F63%2F6%2F1215%3Frss%3D1</link>
            <description>Conclusions
Cefditoren offered higher antibacterial effect than cefuroxime and amoxicillin/clavulanic acid against a mixed population of H. influenzae strains due to its higher activity against &amp;beta;-lactamase-producing strains and those carrying ftsI gene mutations. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2414154</comments>
            <pubDate>Mon, 11 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2414154</guid>        </item>
        <item>
            <title>Temporal effects of antibiotic use and Clostridium difficile infections</title>
            <link>http://www.medworm.com/index.php?rid=2414161&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F63%2F6%2F1272%3Frss%3D1</link>
            <description>Conclusions
These results provide support for antibiotic policies that minimize the use of broad-spectrum penicillins (co-amoxiclav and piperacillin/tazobactam), cephalosporins and fluoroquinolones. (Source: Journal of Antimicrobial Chemotherapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2414161</comments>
            <pubDate>Mon, 11 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2414161</guid>        </item>
        <item>
            <title>Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery</title>
            <link>http://www.medworm.com/index.php?rid=2627950&amp;cid=c_8_13_f&amp;fid=35634&amp;url=http%3A%2F%2Fwww.ijaaonline.com%2Farticle%2FPIIS0924857909001526%2Fabstract%3Frss%3Dyes</link>
            <description>In conclusion, the findings of this pilot study indicate that cefuroxime distributes into the ISF of muscle and s.c. adipose tissue of morbidly obese patients undergoing abdominal surgery. Concentrations in the ISF of soft tissues following a single 1.5g dose may be high enough to prevent infections with Gram-positive organisms but may be insufficient to prevent infections with Gram-negative organisms. (Source: International Journal of Antimicrobial Agents)</description>
            <author>International Journal of Antimicrobial Agents</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2627950</comments>
            <pubDate>Sun, 03 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2627950</guid>        </item>
        <item>
            <title>Synthesis, structural characterization and antibacterial activity of novel 7beta-{[3-(substituted phenyl)-2-propenoyl]amino}-3-[(2,5-dihydro-6-hydroxy-2-methyl)-5-oxo-cis-triazin-3-yl]-thiomethyl-cefalosporins.</title>
            <link>http://www.medworm.com/index.php?rid=2545210&amp;cid=c_8_59_f&amp;fid=37263&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19442219%26dopt%3DAbstract</link>
            <description>Authors: Rodr&amp;#xED;guez Z, L&amp;#xF3;pez MA, Gonz&amp;#xE1;lez M, Tol&amp;#xF3;n B, Nadal L, Gonz&amp;#xE1;lez L, V&amp;#xE9;lez H, Fini A
    A series of 3-[(2,5-dihydro-6-hydroxy-2-methyl)-5-oxo-cis-triazin-3-yl]-thiomethyl-cefalosporins with various 3-phenyl-2-propenoyl substituted groups at the 7beta-position were synthesized, structurally characterized and evaluated for antibacterial activity in vitro. To prepare these derivatives by the Vilsmeier's reagent method, it was necessary to carefully control the reaction conditions in order to avoid the formation of the biologically inactive alpha epimer. The NMR studies showed that the 3-phenyl-2-propenoyl moiety has little effect on chemical shifts of cephem nucleus protons and carbon atoms. Some of these cephalosporin derivatives showed good in vitro activ...</description>
            <author>Medicinal Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2545210</comments>
            <pubDate>Thu, 30 Apr 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2545210</guid>        </item>
        <item>
            <title>Bacterial colonization of stimulation electrode wires in patients undergoing temporary sacral nerve stimulation</title>
            <link>http://www.medworm.com/index.php?rid=3187018&amp;cid=c_8_17_f&amp;fid=32953&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1463-1318.2009.01896.x</link>
            <description>Conclusion Bacterial colonization of the temporary stimulation wire is common but appears to be associated with a low risk of clinical infection. A single peri-operative dose of antibiotics does not appear to prevent colonization. (Source: Colorectal Disease)</description>
            <author>Colorectal Disease</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3187018</comments>
            <pubDate>Mon, 13 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3187018</guid>        </item>
        <item>
            <title>Antibiotic therapy improves psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2332412&amp;cid=c_8_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F81814%2FPsoriasis%2FAntibiotic_therapy_improves_psoriasis.html</link>
            <description>Antibiotic therapy may improve psoriatic skin lesions, report researchers after studying long-term cefuroxime axetil administration. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2332412</comments>
            <pubDate>Fri, 10 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2332412</guid>        </item>
        <item>
            <title>Improvement of psoriasis after antibiotic therapy with cefuroxime axetil</title>
            <link>http://www.medworm.com/index.php?rid=2476193&amp;cid=c_8_12_f&amp;fid=38739&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-3083.2009.03145.x</link>
            <description>(Source: Journal of the European Academy of Dermatology and Venereology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of the European Academy of Dermatology and Venereology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2476193</comments>
            <pubDate>Thu, 02 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2476193</guid>        </item>
        <item>
            <title>Bartholinitis caused by Streptococcus pneumoniae: case report and review of literature.</title>
            <link>http://www.medworm.com/index.php?rid=2314758&amp;cid=c_8_32_f&amp;fid=37104&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19332936%26dopt%3DAbstract</link>
            <description>Authors: Parvathi S, Imara AS, Thoduka TG
    Most of the Bartholin's gland abscesses have been thought to be caused by colonizing micro-organisms of the perineal region. We encountered an interesting case of acute Bartholins abscess caused by Streptococcus pneumoniae in a primigravida. The abscess was incised and drained. The patient was treated with Cefuroxime. This case is presented for its rarity.
    PMID: 19332936 [PubMed - in process] (Source: Indian Journal of Pathology and Microbiology)</description>
            <author>Indian Journal of Pathology and Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2314758</comments>
            <pubDate>Wed, 01 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2314758</guid>        </item>
        <item>
            <title>Cefuroxime axetil/furosemide interaction: First report of an interaction, leading to fatal toxic epidermal necrolysis and granulocytopenia in an elderly patient: case report.</title>
            <link>http://www.medworm.com/index.php?rid=2287941&amp;cid=c_8_13_f&amp;fid=34372&amp;url=http%3A%2F%2Freactions.adisonline.com%2Fpt%2Fre%2Frea%2Fabstract.00128415-200912440-00033.htm</link>
            <description>Page: 12 (Source: Reactions Weekly)</description>
            <author>Reactions Weekly</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2287941</comments>
            <pubDate>Wed, 25 Mar 2009 07:36:49 +0100</pubDate>
            <guid isPermaLink="false">2287941</guid>        </item>
        <item>
            <title>Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance</title>
            <link>http://www.medworm.com/index.php?rid=2281118&amp;cid=c_8_46_f&amp;fid=37239&amp;url=http%3A%2F%2Fijsa.rsmjournals.com%2Fcgi%2Fcontent%2Fshort%2F20%2F4%2F225%3Frss%3D1</link>
            <description>In conclusion, It is crucial to develop treatment guidelines according to regional antimicrobial resistances and educational programmes to improve clinical care for genital gonococcal diseases. (Source: International Journal of STD and AIDS)</description>
            <author>International Journal of STD and AIDS</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2281118</comments>
            <pubDate>Fri, 20 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2281118</guid>        </item>
        <item>
            <title>Activity of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages, keratinocytes) forms of Methicillin-Sensitive (MSSA) and Methicillin-Resistant Staphylococcus aureus (MRSA).</title>
            <link>http://www.medworm.com/index.php?rid=2274378&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19289525%26dopt%3DAbstract</link>
            <description>Authors: Lemaire S, Glupczynski Y, Duval V, Joris B, Tulkens PM, Van Bambeke F
    S. aureus is an opportunistic intracellular organism. Although poorly accumulating in eukaryotic cells, beta-lactams show activity against intracellular MSSA if exposure times and drug concentrations are sufficient. Intraphagocytic MRSA are susceptible to penicillins and carbapenems because acidic pH favors the acylation of PBP 2a by these beta-lactams through pH-induced conformational change. Ceftobiprole, showing almost similar in vitro activities against MRSA and MSSA in broth, was examined for intracellular activity (THP-1 macrophages, keratinocytes) against a panel of hospital-acquired and community-acquired MRSA (MICs: 0.5-2.0 mg/L at pH 7.4 and 0.25-1.0 mg/L at pH 5.5) vs. MSSA isolates, with measurem...</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2274378</comments>
            <pubDate>Mon, 16 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2274378</guid>        </item>
        <item>
            <title>Cefuroxime: Acute tubulointerstitial nephritis: case report</title>
            <link>http://www.medworm.com/index.php?rid=2251590&amp;cid=c_8_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2009%2F00000001%2F00001242%2Fart00040</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2251590</comments>
            <pubDate>Wed, 11 Mar 2009 13:52:59 +0100</pubDate>
            <guid isPermaLink="false">2251590</guid>        </item>
        <item>
            <title>Susceptibility patterns of clinical and fish isolates of Laribacter hongkongensis: comparison of the Etest, disc diffusion and broth microdilution methods</title>
            <link>http://www.medworm.com/index.php?rid=2259814&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F63%2F4%2F704%3Frss%3D1</link>
            <description>Conclusions
Etest and disc diffusion appear to be reliable for evaluation of susceptibilities of L. hongkongensis to imipenem, ciprofloxacin and tetracycline. However, these methods may underestimate resistance to other &amp;beta;-lactams. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2259814</comments>
            <pubDate>Tue, 10 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2259814</guid>        </item>
        <item>
            <title>Comparison of antimicrobial resistance patterns between clinical and sewage isolates in a regional hospital in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=2259787&amp;cid=c_8_77_f&amp;fid=32054&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1472-765X.2009.02572.x</link>
            <description>Conclusions: The sewage isolates had higher antimicrobial resistance rates than the clinical isolates from the same hospital.Significance and Impact of the Study: The low efficacy of the hospital sewage treatment may contribute to the dissemination of multidrug resistant bacteria from this hospital compartments to the environment. Practices which limit the disposal of antimicrobial agents into the wastewater system may be the possible measure to prevent the selection of multidrug-resistant bacteria from sewage treatment plants. (Source: Letters in Applied Microbiology)</description>
            <author>Letters in Applied Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2259787</comments>
            <pubDate>Mon, 09 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2259787</guid>        </item>
        <item>
            <title>Cefuroxime: Acute tubulointerstitial nephritis: case report.</title>
            <link>http://www.medworm.com/index.php?rid=2240306&amp;cid=c_8_13_f&amp;fid=34372&amp;url=http%3A%2F%2Freactions.adisonline.com%2Fpt%2Fre%2Frea%2Fabstract.00128415-200912420-00040.htm</link>
            <description>Page: 14 (Source: Reactions Weekly)</description>
            <author>Reactions Weekly</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2240306</comments>
            <pubDate>Sat, 07 Mar 2009 03:20:47 +0100</pubDate>
            <guid isPermaLink="false">2240306</guid>        </item>
        <item>
            <title>Giant Cell Tubulitis With Immune Complex Deposits in a Patient With Lupus Nephritis</title>
            <link>http://www.medworm.com/index.php?rid=2206514&amp;cid=c_8_47_f&amp;fid=33205&amp;url=http%3A%2F%2Fwww.ajkd.org%2Farticle%2FPIIS0272638608013632%2Fabstract%3Frss%3Dyes</link>
            <description>We report a case of acute tubulointerstitial nephritis with giant cell tubulitis and tubular basement membrane immune complex deposits in a patient with membranous lupus nephritis. The patient, who had no prior evidence of lupus nephritis, developed acute kidney failure and mild proteinuria after cardiac valve replacement surgery. Giant cell tubulitis with tubular basement membrane immune complex deposits has been described in 4 patients after cardiac surgery, 3 of whom received cefuroxime, suggesting the possibility of a drug hypersensitivity reaction. The present case suggests there may also be a pathogenetic role for autoimmunity in this condition. (Source: American Journal of Kidney Diseases)</description>
            <author>American Journal of Kidney Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2206514</comments>
            <pubDate>Mon, 23 Feb 2009 11:40:30 +0100</pubDate>
            <guid isPermaLink="false">2206514</guid>        </item>
        <item>
            <title>Intracellular activity of antibiotics against Staphylococcus aureus in the mouse peritonitis model.</title>
            <link>http://www.medworm.com/index.php?rid=2202236&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19223616%26dopt%3DAbstract</link>
            <description>Authors: Sandberg A, Hessler JH, Skov RL, Blom J, Frimodt-M&amp;#xF8;ller N
    Antibiotic treatment of Staphylococcus aureus infections is often problematic due to slow response to therapy and high frequency of infection recurrence. Intracellular persistence of the staphylococci has been recognized and could offer a good explanation for these treatment difficulties. Knowledge of the interplay between intracellular antibiotic activity and the overall infection outcome is therefore important. Several intracellular in vitro models have been developed, but few experimental animal models have been published. The mouse peritonitis/sepsis model was used as the basic in vivo model exploring a quantitative ex vivo extra- and intracellular differentiation assay. Intracellular presence of S. aureus was ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2202236</comments>
            <pubDate>Tue, 17 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2202236</guid>        </item>
        <item>
            <title>Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics</title>
            <link>http://www.medworm.com/index.php?rid=2176952&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F63%2F3%2F511%3Frss%3D1</link>
            <description>Conclusions
Despite high rates of &amp;beta;-lactamase production among non-typeable H. influenzae and M. catarrhalis, multiple oral treatment options exist for non-typeable H. influenzae and M. catarrhalis. Multidrug-resistant serotype 19A S. pneumoniae (~20%) limits treatment options for ambulatory S. pneumoniae respiratory disease. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2176952</comments>
            <pubDate>Wed, 11 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2176952</guid>        </item>
        <item>
            <title>Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt 2000-2006 - phenotypic and genotypic perspectives.</title>
            <link>http://www.medworm.com/index.php?rid=2157636&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19188396%26dopt%3DAbstract</link>
            <description>In conclusion, N. meningitidis isolates from the African meningitis belt remain highly susceptible to the antibiotics used. Regarding ss-lactam antibiotics, rare isolates showed a reduced susceptibility to penicillins, but the expanded-spectrum cephalosporins are not affected at present.
    PMID: 19188396 [PubMed - as supplied by publisher] (Source: Antimicrobial Agents and Chemotherapy)</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2157636</comments>
            <pubDate>Mon, 02 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2157636</guid>        </item>
        <item>
            <title>Individual behavioral differences in recovery from abdominal sepsis in rats</title>
            <link>http://www.medworm.com/index.php?rid=2152461&amp;cid=c_8_39_f&amp;fid=33375&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fux467062j274v6j6%2F</link>
            <description>Conclusion:&amp;nbsp;&amp;nbsp;Improvement of sickness behavior in sepsis with G-CSF/antibiotic prophylaxis is a promising approach. The course of recovery
 from sepsis may depend on premorbid individual differences.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s00011-008-8223-2Authors
		A. Bauhofer, Philipps-University of Marburg Institute of Theoretical Surgery 35043 Marburg GermanyY.-J. Ho, Chung Shan Medical University School of Psychology Tai-Chung 402 Taiwan, ROCA. Schmitt, Philipps-University of Marburg Institute of Theoretical Surgery 35043 Marburg GermanyM. Köster, Philipps-University of Marburg Institute of Theoretical Surgery 35043 Marburg GermanyR. K. W. Schwarting, Philipps-University of Marburg Experimental and Physiological Psychology 35032 Marburg GermanyC. R. Pawlak, Central In...</description>
            <author>Inflammation Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2152461</comments>
            <pubDate>Sat, 31 Jan 2009 07:41:07 +0100</pubDate>
            <guid isPermaLink="false">2152461</guid>        </item>
        <item>
            <title>Microbiology of odontogenic infections in deep neck spaces: A retrospective study</title>
            <link>http://www.medworm.com/index.php?rid=3161091&amp;cid=c_8_16_f&amp;fid=34579&amp;url=http%3A%2F%2Fwww.bjoms.com%2Farticle%2FPIIS0266435608006128%2Fabstract%3Frss%3Dyes</link>
            <description>This study was therefore initiated to determine whether this change in prescribing was justified. A total of 75 cases were retrospectively identified by scrutiny of the operating theatre data. These patients presented with significant DNSOI that required surgical drainage. Streptococcus milleri and mixed anaerobes were predominant. Only in three cases (4%) there were penicillin-resistant microorganisms. The substitution of benzylpenicillin for cefuroxime as an initial empiric therapy for DNSOI seems likely to have been equally efficacious in the large majority of cases. On the other hand, studies in preference of cephalosporins are based on in vitro trials. A multi-centre randomized controlled clinical trial directly comparing initial empiric second-generation cephalosporin therapy with be...</description>
            <author>The British Journal of Oral &amp; Maxillofacial Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3161091</comments>
            <pubDate>Thu, 29 Jan 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3161091</guid>        </item>
        <item>
            <title>Microbiology of odontogenic infections in deep neck spaces: A retrospective study.</title>
            <link>http://www.medworm.com/index.php?rid=2149542&amp;cid=c_8_16_f&amp;fid=34579&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19178989%26dopt%3DAbstract</link>
            <description>This study was therefore initiated to determine whether this change in prescribing was justified. A total of 75 cases were retrospectively identified by scrutiny of the operating theatre data. These patients presented with significant DNSOI that required surgical drainage. Streptococcus milleri and mixed anaerobes were predominant. Only in three cases (4%) there were penicillin-resistant microorganisms. The substitution of benzylpenicillin for cefuroxime as an initial empiric therapy for DNSOI seems likely to have been equally efficacious in the large majority of cases. On the other hand, studies in preference of cephalosporins are based on in vitro trials. A multi-centre randomized controlled clinical trial directly comparing initial empiric second-generation cephalosporin therapy with be...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>The British Journal of Oral &amp; Maxillofacial Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2149542</comments>
            <pubDate>Tue, 27 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2149542</guid>        </item>
        <item>
            <title>Cefuroxime Superior to Penicillin for Pediatric Perianal Streptococcal Dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=2118293&amp;cid=c_8_20_f&amp;fid=33134&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F586991%3Fsrc%3Drss</link>
            <description>Cefuroxime was more effective than penicillin in a Swiss study for the treatment of perianal Streptococcal dermatitis in children &quot;and therefore should be considered as the treatment of choice,&quot; the investigators say.  Reuters Health Information (Source: Medscape Infectious Diseases Headlines)</description>
            <author>Medscape Infectious Diseases Headlines</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2118293</comments>
            <pubDate>Tue, 20 Jan 2009 18:43:08 +0100</pubDate>
            <guid isPermaLink="false">2118293</guid>        </item>
        <item>
            <title>Cefuroxime for Empiric Treatment of Community-Acquired Pneumococcal Pneumonia: Is There a Generation Gap?</title>
            <link>http://www.medworm.com/index.php?rid=2104081&amp;cid=c_8_6_f&amp;fid=33554&amp;url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fdoi%3D192393</link>
            <description>Chemotherapy 2009;55:97-104 (DOI:10.1159/000192393) (Source: Karger Publishers)</description>
            <author>Karger Publishers</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2104081</comments>
            <pubDate>Wed, 14 Jan 2009 15:07:32 +0100</pubDate>
            <guid isPermaLink="false">2104081</guid>        </item>
        <item>
            <title>CEFTIN (Cefuroxime Axetil) Powder, For Suspension CEFTIN (Cefuroxime Axetil) Tablet, Film Coated [GlaxoSmithKline]</title>
            <link>http://www.medworm.com/index.php?rid=2081243&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D8849</link>
            <description>Updated Date: Jan 5, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2081243</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2081243</guid>        </item>
        <item>
            <title>Community-acquired urinary tract infections in Southern Turkey: etiology and antimicrobial resistance.</title>
            <link>http://www.medworm.com/index.php?rid=2178687&amp;cid=c_8_47_f&amp;fid=38079&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19203547%26dopt%3DAbstract</link>
            <description>In this study, we compared the distribution and antibiotic susceptibility patterns of bacterial strains isolated from patients with community-acquired urinary tract infections in Southern Turkey, Hatay, during 2004 and 2005. The majority (82.3%) of the isolates were from women while the remaining (17.7%) were from men. Of all samples tested, 49% were culture-positive with a bacterial pathogen. The most frequently isolated bacterial species were Escherichia coli (45.1%), coagulase-negative Staphylococcus (CNS) (15.5%) and Klebsiella spp. (10.9%). E. coli was more prevalent in women (p &amp;lt; 0.05) while Klebsiella spp., Proteus spp. and Pseudomonas spp. were found more prevalent in men (p &amp;lt; 0.05). Increasing resistance to gentamicin, amikacin and cefazolin, and decreased resistance to cipr...</description>
            <author>Clinical Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2178687</comments>
            <pubDate>Thu, 01 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2178687</guid>        </item>
        <item>
            <title>Kinetic spectrofluorimetric determination of certain cephalosporins in human plasma.</title>
            <link>http://www.medworm.com/index.php?rid=2047778&amp;cid=c_8_59_f&amp;fid=36096&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19084655%26dopt%3DAbstract</link>
            <description>Authors: Omar MA, Abdelmageed OH, Attia TZ
    An accurate, reliable, specific and sensitive kinetic spectrofluorimetric method was developed for the determination of seven cephalosporin antibiotics namely cefotaxime sodium, cephapirin sodium, cephradine dihydrate, cephalexin monohydrate, cefazoline sodium, ceftriaxone sodium and cefuroxime sodium. The method is based on their degradation under an alkaline condition producing fluorescent products. The factors affecting the degradation and the determination were studied and optimized. The reaction is followed spectrofluorimetrically by measuring the rate of change of fluorescence intensity at specified emission wavelength. The initial rate and fixed time methods were used for the construction of calibration graphs to determine the concentra...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Talanta</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047778</comments>
            <pubDate>Thu, 18 Dec 2008 12:50:08 +0100</pubDate>
            <guid isPermaLink="false">2047778</guid>        </item>
        <item>
            <title>[Analysis of antibiotic consumption and microorganism resistance changes]</title>
            <link>http://www.medworm.com/index.php?rid=2038962&amp;cid=c_8_44_f&amp;fid=30533&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19001833%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In 2004-2007, the usage of piperacillin and tazobactam, metronidazole, cefuroxime, meropenem, cefoperazone, and sulbactam increased. In 2006-2007, ofloxacin consumption decreased. The changes in other antibiotic usage were statistically insignificant. In 2004-2007, E. coli and K. pneumoniae resistance to ampicillin and sulbactam, cefuroxime, ciprofloxacin, gentamicin and E. coli resistance to ampicillin increased. A statistically significant positive correlation between quinolone consumption and K. pneumoniae resistance to ciprofloxacin was determined.
    PMID: 19001833 [PubMed - in process] (Source: Medicina (Kaunas))</description>
            <author>Medicina (Kaunas)</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2038962</comments>
            <pubDate>Wed, 17 Dec 2008 06:57:45 +0100</pubDate>
            <guid isPermaLink="false">2038962</guid>        </item>
        <item>
            <title>Prospective controlled study of microbial colonization of the trachea in tracheotomized and laryngectomized patients with HME (heat and moisture exchanger).</title>
            <link>http://www.medworm.com/index.php?rid=2044469&amp;cid=c_8_16_f&amp;fid=25315&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19085182%26dopt%3DAbstract</link>
            <description>Conclusion: The use of heat and moisture exchangers (HMEs) does not endanger tracheostomy patients in terms of additional exposure to pathogenic microorganisms. Objective: Stoma filters in the form of HMEs cause a beneficial convection of respiratory air in tracheotomized and laryngectomized patients. We investigated whether or not this may lead to an altered microbial ecology in the non-physiologically colonized lower respiratory tract. Materials and methods: To test this hypothesis, material from the trachea of stoma patients was prospectively collected utilizing a standardized swab technique and subsequent aerobic quantitative culture assays of the suspended and serially diluted material. With this approach, we examined the microbial flora in 6 and 5 patients after laryngectomy/tracheos...</description>
            <author>Acta Oto-Laryngologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2044469</comments>
            <pubDate>Wed, 10 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2044469</guid>        </item>
        <item>
            <title>Cefuroxime-induced pemphigus erythematosus in a young boy.</title>
            <link>http://www.medworm.com/index.php?rid=2043176&amp;cid=c_8_12_f&amp;fid=38064&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19077088%26dopt%3DAbstract</link>
            <description>Authors: Baroni A, Puca RV, Aiello FS, Palla M, Faccenda F, Vozza G, Sangiuliano S, Ruocco E
    Summary Pemphigus erythematosus (Senear-Usher syndrome) is a variant of superficial pemphigus with features of both lupus erythematosus and pemphigus. It affects mainly middle-aged adults, and is rarely observed before the age of 20 years. The case of a 14-year-old boy who showed cutaneous lesions suggestive for pemphigus erythematosus is described. Not all laboratory and histopathological investigations confirmed the hypothesis, so a diagnosis of clinical pemphigus erythematosus was made. Systemic steroid therapy was effective in controlling the disease. This case is interesting because of the rare occurrence of pemphigus erythematosus in adolescence and the possibility of another drug being a...</description>
            <author>Clinical And Experimental Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2043176</comments>
            <pubDate>Tue, 09 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2043176</guid>        </item>
        <item>
            <title>Antimicrobial resistance of bacterial agents of the upper respiratory tract of school children in Buea, Cameroon.</title>
            <link>http://www.medworm.com/index.php?rid=2043343&amp;cid=c_8_46_f&amp;fid=37922&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19069618%26dopt%3DAbstract</link>
            <description>Authors: Ndip RN, Ntiege EA, Ndip LM, Nkwelang G, Akoachere JF, Akenji T N
    The study was aimed at determining bacterial agents of the upper respiratory tract and the susceptibility patterns of isolates to antibiotics. In total, 200 throat swabs were obtained from students attending different boarding schools within the Buea Municipality and screened to obtain the prevalence of respiratory pathogens and to understand the antibiotic susceptibility patterns of isolates using standard microbiological procedure and the disc-diffusion test. Of the 200 samples screened, 112 (56%) had positive cultures with the dominant bacterial pathogens being Haemophilus influenzae (20%), followed by Streptococcus pneumoniae (15%), Klebsiella pneumoniae (11%), and Staphylococcus aureus (10%). Although 56% o...</description>
            <author>Journal of Health, Population, and Nutrition</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2043343</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2043343</guid>        </item>
        <item>
            <title>The utilization of antibiotics in the management of acute pancreatitis--experience from one transitional country university hospital.</title>
            <link>http://www.medworm.com/index.php?rid=2117512&amp;cid=c_8_54_f&amp;fid=38108&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19149227%26dopt%3DAbstract</link>
            <description>Authors: Marusi&amp;#x107; S, Si&amp;#x107;aja M, Kujundzi&amp;#x107; M, Bani&amp;#x107; M, Jaksi&amp;#x107; O, Vrazi&amp;#x107; H
    The aim of the study was to analyze the evidence-based use of antibiotic therapy in the treatment of acute pancreatitis and to identify factors influencing the introduction of antibiotic therapy in the setting of transitional country clinical hospital. This retrospective study was conducted at Department of Internal Medicine at University Hospital Dubrava in Zagreb, Croatia. Data were collected from hospital records of patients treated for acute pancreatitis from January 1st, 2005 till December 31st, 2005. Data collected from patients' histories were compared with indications for antibiotic treatment and antibiotics with demonstrated therapeutic efficacy in acute pancreatitis whic...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Collegium Antropologicum</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2117512</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2117512</guid>        </item>
        <item>
            <title>[Analysis of antibiotic consumption and microorganism resistance changes.]</title>
            <link>http://www.medworm.com/index.php?rid=1959180&amp;cid=c_8_44_f&amp;fid=30533&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19001833%26dopt%3DAbstract</link>
            <description>CONCLUSIONS. In 2004-2007, the usage of piperacillin and tazobactam, metronidazole, cefuroxime, meropenem, cefoperazone, and sulbactam increased. In 2006-2007, ofloxacin consumption decreased. The changes in other antibiotic usage were statistically insignificant. In 2004-2007, E. coli and K. pneumoniae resistance to ampicillin and sulbactam, cefuroxime, ciprofloxacin, gentamicin and E. coli resistance to ampicillin increased. A statistically significant positive correlation between quinolone consumption and K. pneumoniae resistance to ciprofloxacin was determined.
    PMID: 19001833 [PubMed - in process] (Source: Medicina (Kaunas))</description>
            <author>Medicina (Kaunas)</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1959180</comments>
            <pubDate>Sat, 15 Nov 2008 07:29:24 +0100</pubDate>
            <guid isPermaLink="false">1959180</guid>        </item>
        <item>
            <title>Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness</title>
            <link>http://www.medworm.com/index.php?rid=1958927&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F62%2F6%2F1234%3Frss%3D1</link>
            <description>Conclusions
The multidrug high resistance (precluding adequate oral therapy in children), its origin, the prevalence found in Romania and the presence of non-vaccine (7-valent) serotypes should worry the medical community because of a possible clonal diffusion that would limit therapeutic alternatives. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1958927</comments>
            <pubDate>Fri, 14 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1958927</guid>        </item>
        <item>
            <title>Probability of Achieving Requisite Pharmacodynamic Exposure for Oral beta-Lactam Regimens against Haemophilus influenzae in Children.</title>
            <link>http://www.medworm.com/index.php?rid=1955898&amp;cid=c_8_33_f&amp;fid=36854&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18998749%26dopt%3DAbstract</link>
            <description>CONCLUSION: Against H. influenzae, the antibacterials most likely to achieve optimal in vivo exposures in children are cefpodoxime, ceftibuten, and amoxicillin/clavulanic acid.
    PMID: 18998749 [PubMed - in process] (Source: Paediatric Drugs)</description>
            <author>Paediatric Drugs</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1955898</comments>
            <pubDate>Thu, 13 Nov 2008 16:53:44 +0100</pubDate>
            <guid isPermaLink="false">1955898</guid>        </item>
        <item>
            <title>Cefuroxime axetil: Kounis syndrome in an elderly patient: case report</title>
            <link>http://www.medworm.com/index.php?rid=1927621&amp;cid=c_8_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2008%2F00000001%2F00001226%2Fart00019</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1927621</comments>
            <pubDate>Mon, 03 Nov 2008 10:50:09 +0100</pubDate>
            <guid isPermaLink="false">1927621</guid>        </item>
        <item>
            <title>Cefuroxime axetil: Kounis syndrome in an elderly patient: case report.</title>
            <link>http://www.medworm.com/index.php?rid=1924203&amp;cid=c_8_13_f&amp;fid=34372&amp;url=http%3A%2F%2Freactions.adisonline.com%2Fpt%2Fre%2Frea%2Fabstract.00128415-200812260-00020.htm</link>
            <description>Page: 7 (Source: Reactions Weekly)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions Weekly</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1924203</comments>
            <pubDate>Sat, 01 Nov 2008 10:22:14 +0100</pubDate>
            <guid isPermaLink="false">1924203</guid>        </item>
        <item>
            <title>Estimation of Cefuroxime Dosage Using Pharmacodynamic Targets, MIC Distributions, and Minimization of a Risk Function.</title>
            <link>http://www.medworm.com/index.php?rid=1926131&amp;cid=c_8_13_f&amp;fid=32524&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18974282%26dopt%3DAbstract</link>
            <description>Authors: Viberg A, Cars O, Karlsson MO, J&amp;#xF6;nsson S
    An approach for estimation of dosing strategies based on data-derived models and assessment of the risk associated with deviation from the treatment target is presented. The work is illustrated by establishing a dosing strategy to be used for a priori individualization on the basis of renal function for the antibiotic cefuroxime. Treatment involved exposing patients to concentrations above the minimum inhibitory concentration (MIC) for 50% of the dosing interval. The risk (penalty) function incorporated both deviations from the target and the use of excess amount of drug. Dosing strategies were estimated for a target population by minimizing the risk function. The population was characterized by a population pharmacokinetic model, ...</description>
            <author>The Journal of Clinical Pharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1926131</comments>
            <pubDate>Sat, 01 Nov 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1926131</guid>        </item>
        <item>
            <title>The influence of glucose added urine on the in vitro antimicrobial activity of various antibiotics.</title>
            <link>http://www.medworm.com/index.php?rid=2148448&amp;cid=c_8_61_f&amp;fid=37924&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19179689%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our findings demonstrated that MICs of antibiotics are influenced by the glucose added urine.
    PMID: 19179689 [PubMed - in process] (Source: The Indian Journal of Medical Research)</description>
            <author>The Indian Journal of Medical Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2148448</comments>
            <pubDate>Sat, 01 Nov 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2148448</guid>        </item>
        <item>
            <title>Subcutaneous Fistulae in a Patient with Femoral Hypoplasia due to 
 Actinomyces europaeus
 and 
 Actinomyces turicensis</title>
            <link>http://www.medworm.com/index.php?rid=1883021&amp;cid=c_8_20_f&amp;fid=33374&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb54854n8q48355t7%2F</link>
            <description>We describe a case of chronic fistulae caused by a coinfection with A. europaeus and A. turicensis in an immunocompetent male patient with a severe congenital femur hypoplasia. Actinomycosis is most probably the consequence
 of a postoperative wound infection after a prior surgical intervention. Both Actinomyces species were identified by 16S rRNA gene sequencing. The Actinomyces-caused fistulae were treated by excision and a 1-week course of i.v. vancomycin followed by a 1-week course of p.o. cefuroxime.
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s15010-008-7392-9Authors
		A. E. Zautner, University Hospital Rostock Institute of Medical Microbiology, Virology and Hygiene Schillingallee 70 18057 Rostock GermanyS. Schmitz, University Hospital Rostock Orthopaedic Hospital ...</description>
            <author>Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1883021</comments>
            <pubDate>Wed, 15 Oct 2008 10:55:18 +0100</pubDate>
            <guid isPermaLink="false">1883021</guid>        </item>
        <item>
            <title>Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels</title>
            <link>http://www.medworm.com/index.php?rid=1867523&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F62%2F5%2F986%3Frss%3D1</link>
            <description>Conclusions
This multidrug-resistant phenotype of K. pneumoniae is associated with increased acrA and ramA transcription and decreased ompK35 transcription. Since the cefuroxime resistance was not reversed by PA&amp;beta;N, it was probably attributable to decreased levels of OmpK35, rather than to efflux. (Source: Journal of Antimicrobial Chemotherapy)</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1867523</comments>
            <pubDate>Fri, 10 Oct 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1867523</guid>        </item>
        <item>
            <title>Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).</title>
            <link>http://www.medworm.com/index.php?rid=1856361&amp;cid=c_8_13_f&amp;fid=35634&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18835763%26dopt%3DAbstract</link>
            <description>The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum beta-lactamases (ESBLs) and methicillin resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates. Pathogens causing respiratory tract infections in hospitalised patients were prospectively collected from all over Germany. Drugs tested by Etest included moxifloxacin, levofloxacin, amoxicillin/clavulanic acid, cefuroxime, clarithromycin and penicillin G. ESBL production by K. pneumoniae was determined using cefotaxime/ceftazidime+/-cl...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>International Journal of Antimicrobial Agents</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1856361</comments>
            <pubDate>Tue, 30 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1856361</guid>        </item>
        <item>
            <title>[beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes.]</title>
            <link>http://www.medworm.com/index.php?rid=1798951&amp;cid=c_8_13_f&amp;fid=37253&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18792814%26dopt%3DAbstract</link>
            <description>Authors: Lerma M, Cebri&amp;#xE1;n L, Gim&amp;#xE9;nez M, Coronel P, Gimeno M, Aguilar L, Garc&amp;#xED;a de Lomas J
    Susceptibility to beta-lactams was determined in 203 recent Spanish E. coli isolates from urinary tract infections exhibiting different resistance phenotypes: a) susceptible (n = 60); b) quinolone-resistant (n = 45); c) penicillinase (n=64); d) hyperproduction of penicillinase (n=8); e) inhibitor resistant TEM (IRT) (n=18), and f) extended spectrum betalactamase (ESBL) (n=8).Minimum inhibitory concentration (MIC) determination by agar dilution and susceptibility tests for ESBL detection by macrodilution were performed following CLSI recommendations. All the beta-lactams tested showed high activity against susceptible and penicillinase phenotypes, with close to 100 % susceptibility. ...</description>
            <author>Revista Espanola de Quimioterapia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1798951</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1798951</guid>        </item>
        <item>
            <title>beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes.</title>
            <link>http://www.medworm.com/index.php?rid=1948171&amp;cid=c_8_13_f&amp;fid=37253&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18792814%26dopt%3DAbstract</link>
            <description>Authors: Lerma M, Cebri&amp;#xE1;n L, Gim&amp;#xE9;nez M, Coronel P, Gimeno M, Aguilar L, Garc&amp;#xED;a de Lomas J
    Susceptibility to beta-lactams was determined in 203 recent Spanish E. coli isolates from urinary tract infections exhibiting different resistance phenotypes: a) susceptible (n = 60); b) quinolone-resistant (n = 45); c) penicillinase (n=64); d) hyperproduction of penicillinase (n=8); e) inhibitor resistant TEM (IRT) (n=18), and f) extended spectrum betalactamase (ESBL) (n=8).Minimum inhibitory concentration (MIC) determination by agar dilution and susceptibility tests for ESBL detection by macrodilution were performed following CLSI recommendations. All the beta-lactams tested showed high activity against susceptible and penicillinase phenotypes, with close to 100 % susceptibility. ...</description>
            <author>Revista Espanola de Quimioterapia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1948171</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1948171</guid>        </item>
        <item>
            <title>Hypersensitivity to clavulanic acid in children.</title>
            <link>http://www.medworm.com/index.php?rid=2041184&amp;cid=c_8_3_f&amp;fid=36887&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19080805%26dopt%3DAbstract</link>
            <description>We present 10 cases (6 males and 4 females) of children aged 4 to 12 years, who were diagnosed with allergy to clavulanic acid (CL) and treated in the Paediatric Allergy Section of the University Hospital Dr. Peset in Valencia from 2000 to 2005. The children reported symptoms of urticaria and angio-oedema after receiving orally-administered amoxicillin/clavulanic acid (A-CL) for an infection. Diagnosis was based on the confirmation of an IgE-mediated aetiology by an oral challenge test with amoxicillin-clavulanic acid. Following negative skin test results and CAP for penicilloyl G and V, amoxicillin, ampicillin and cefaclor &amp;lt; 0.35 KU/l, those patients who were allergic to clavulanic acid (positive oral challenge test) were shown to be tolerant to orally-administered Cefuroxime axetil.
 ...</description>
            <author>Allergologia et Immunopathologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2041184</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2041184</guid>        </item>
        <item>
            <title>Pharmacodynamic Target Attainment of Oral beta-Lactams for the Empiric Treatment of Acute Otitis Media in Children.</title>
            <link>http://www.medworm.com/index.php?rid=1747586&amp;cid=c_8_33_f&amp;fid=36854&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18754699%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Based on the recent epidemiologic and resistance profiles of S. pneumoniae and H. influenzae, amoxicillin/clavulanic acid (45 mg/kg every 12 hours) and cefpodoxime (5 mg/kg every 12 hours) provide the greatest likelihood of achieving optimal pharmacodynamic exposures empirically in children with AOM.
    PMID: 18754699 [PubMed - in process] (Source: Paediatric Drugs)</description>
            <author>Paediatric Drugs</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1747586</comments>
            <pubDate>Sun, 31 Aug 2008 13:27:11 +0100</pubDate>
            <guid isPermaLink="false">1747586</guid>        </item>
        <item>
            <title>In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.</title>
            <link>http://www.medworm.com/index.php?rid=1726486&amp;cid=c_8_77_f&amp;fid=35514&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18715733%26dopt%3DAbstract</link>
            <description>Authors: Seral C, Su&amp;#xE1;rez L, Rubio-Calvo C, G&amp;#xF3;mez-Lus R, Gimeno M, Coronel P, Dur&amp;#xE1;n E, Becerril R, Oca M, Castillo FJ
    In vitro cefditoren antimicrobial activity was tested against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in our hospital from January 2005 to May 2006 by agar dilution and broth microdilution method, respectively. MICs were also determined for 13 and 10 comparison drugs, respectively. The pneumococci tested comprised 113 (39.2%) penicillin susceptible, 91 (31.6%) penicillin intermediate, and 84 (29.2%) penicillin resistant. Cefditoren was the most active drug on the basis of the MICs (MIC(90) = 0.5 mug/mL), followed by ceftriaxone and levofloxacin (MIC(90) = 1 mug/mL). Cefditoren MICs ranged from 0.25 to 1 mug/mL ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Diagnostic Microbiology and Infectious Disease</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1726486</comments>
            <pubDate>Tue, 19 Aug 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1726486</guid>        </item>
        <item>
            <title>Cefuroxime Prophylaxis Is Effective in Noninstrumented Spine Surgery: A Double-Blind, Placebo-Controlled Study.</title>
            <link>http://www.medworm.com/index.php?rid=1708215&amp;cid=c_8_31_f&amp;fid=34147&amp;url=http%3A%2F%2Fwww.spinejournal.com%2Fpt%2Fre%2Fspine%2Fabstract.00007632-200808150-00002.htm</link>
            <description>The impact of antibiotic prophylaxis was never proven in herniated disc surgery. In a double-blind trial, 1 preoperative 1.5 g dose of cefuroxime significantly prevented organ-space infections in this setting: spondylodiscitis or epidural abscess occurred in 0/613 patients who received cefuroxime, compared with 9/624 patients who received placebo.Page: 1919DOI: 10.1097/BRS.0b013e31817d97cfAuthors: Petignat, Christiane MD *; Francioli, Patrick MD *; Harbarth, Stephan MD, MS +; Regli, Luca MD ++; Porchet, Francois MD ++; Reverdin, Alain MD [S]; Rilliet, Benedict MD [S]; de Tribolet, Nicolas MD [S]; Pannatier, Andre PharmD [P]; Pittet, Didier MD, PhD +; Zanetti, Giorgio MD, MS * (Source: Spine)</description>
            <author>Spine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1708215</comments>
            <pubDate>Sun, 17 Aug 2008 10:20:40 +0100</pubDate>
            <guid isPermaLink="false">1708215</guid>        </item>
        <item>
            <title>Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006</title>
            <link>http://www.medworm.com/index.php?rid=1713668&amp;cid=c_8_47_f&amp;fid=33391&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw48ww7127m401086%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Empirical antibiotic selection should be based on knowledge of the local prevalence of bacterial organisms and antibiotic
 sensitivities, because resistance patterns may vary in different regions.
 
 
 
	Content Type Journal ArticleCategory Nephrology - Original PaperDOI 10.1007/s11255-008-9445-5Authors
		Ferhat Catal, Fatih University Medical School Department of Pediatrics Ankara TurkeyNuket Bavbek, Fatih University Medical School Department of Nephrology Ankara TurkeyOmer Bayrak, Fatih University Medical School Department of Urology Ankara TurkeyMusemma Karabel, Fatih University Medical School Department of Pediatrics Ankara TurkeyDuran Karabel, Fatih University Medical School Department of Pediatrics Ankara TurkeyEnder Odemis, Fatih University Medical School Depa...</description>
            <author>International Urology and Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1713668</comments>
            <pubDate>Fri, 15 Aug 2008 07:15:37 +0100</pubDate>
            <guid isPermaLink="false">1713668</guid>        </item>
        <item>
            <title>Randomized, Comparative Efficacy Trial of Oral Penicillin Versus Cefuroxime for Perianal Streptococcal Dermatitis in Children.</title>
            <link>http://www.medworm.com/index.php?rid=1697870&amp;cid=c_8_33_f&amp;fid=37695&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18692203%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Cefuroxime was more effective than penicillin and therefore should be considered as the treatment of choice for perianal dermatitis due to GABHS.
    PMID: 18692203 [PubMed - as supplied by publisher] (Source: The Journal of Pediatrics)</description>
            <author>The Journal of Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1697870</comments>
            <pubDate>Fri, 08 Aug 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1697870</guid>        </item>
        <item>
            <title>Comparative Analysis of Antibiotic Resistance Characteristics of Gram-negative Bacteria Isolated from Laying Hens and Eggs in Conventional and Organic Keeping Systems in Bavaria, Germany.</title>
            <link>http://www.medworm.com/index.php?rid=1675201&amp;cid=c_8_20_f&amp;fid=35860&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18667026%26dopt%3DAbstract</link>
            <description>Authors: Schwaiger K, Schmied EM, Bauer J
    By investigating the prevalence and resistance characteristics of Gram-negative bacteria from organic and conventional kept laying hens against 31 (Campylobacter: 29) different antibiotics using the microdilution method, we determined to what extent different keeping systems influence bacterial resistance patterns. For this purpose, samples from 10 organic and 10 conventional flocks in Bavaria (Germany) were investigated four times between January 2004 and April 2005. Altogether, 799 cloacal swabs and 800 eggs (contents and shells) were examined. The bacterial investigation performed with standardized cultural methods showed prevalence for all bacteria groups in about the same order of magnitude in the two different keeping systems: Salmonella ...</description>
            <author>Zoonoses and Public Health</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1675201</comments>
            <pubDate>Sat, 02 Aug 2008 15:45:31 +0100</pubDate>
            <guid isPermaLink="false">1675201</guid>        </item>
        <item>
            <title>Sagent Pharmaceuticals Launches Ceftriaxone, USP, And Cefuroxime For Injection, USP</title>
            <link>http://www.medworm.com/index.php?rid=1632132&amp;cid=c_8_34_f&amp;fid=37087&amp;url=http%3A%2F%2Fwww.pharmaceuticalonline.com%2Farticle.mvc%2FSagent-Launches-Ceftriaxone-And-Cefuroxime-0001%3Fatc%7Ec%3D771%2Bs%3D773%2Br%3D001%2Bl%3Da</link>
            <description>Sagent Pharmaceuticals, Inc., recently announced that it has launched both ceftriaxone for injection, USP, and cefuroxime for injection, USP, two broad spectrum antibiotics for parenteral administration used to treat bacterial infections. (Source: Pharmaceutical Online News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Pharmaceutical Online News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1632132</comments>
            <pubDate>Wed, 16 Jul 2008 12:12:00 +0100</pubDate>
            <guid isPermaLink="false">1632132</guid>        </item>
        <item>
            <title>BSAC standardized disc susceptibility testing method (version 7)</title>
            <link>http://www.medworm.com/index.php?rid=1602084&amp;cid=c_8_77_f&amp;fid=32011&amp;url=http%3A%2F%2Fjac.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F62%2F2%2F256%3Frss%3D1</link>
            <description>The changes that have been made to the previous version of the recommendations (version 6) are as follows: medium and incubation condition for testing Acinetobacter spp. (Tables&amp;nbsp;1 and 6); use of cefoxitin as an indicator antibiotic for detecting methicillin/oxacillin/cefoxitin resistance in coagulase-negative staphylococci (Tables&amp;nbsp;1, 6 and 11); MIC breakpoint for co-trimoxazole based on the trimethoprim concentration in a 1:19 combination with sulfamethoxazole (Tables&amp;nbsp;7, 10, 11, 12, 15, 16 and 19); advice on the use of azithromycin for the treatment of infections with Salmonella typhi (footnote to Table&amp;nbsp;7); amendment to the recommendation for cefuroxime for the treatment of infections with Proteus mirabilis (footnote Table&amp;nbsp;7); MIC and zone diameter breakpoints for ...</description>
            <author>Journal of Antimicrobial Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1602084</comments>
            <pubDate>Thu, 10 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1602084</guid>        </item>
        <item>
            <title>Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese children's hospitals (2002-2006).</title>
            <link>http://www.medworm.com/index.php?rid=1616379&amp;cid=c_8_13_f&amp;fid=35634&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18614338%26dopt%3DAbstract</link>
            <description>This study surveyed the pattern of inpatient antibiotic use in five Chinese children's hospitals between 2002 and 2006, focusing on the antibiotics accounting for 90% of the volume utilised as well as the level of adherence to guidelines. The Anatomical Therapeutical Chemical Classification/Defined Daily Doses (ATC/DDD) and the drug utilisation 90% (DU90%) methodologies were used. In October 2004, national antibiotic guidelines were issued that divided antibiotics into non-restricted, restricted and special use grades. In five children's hospitals, a total of 56 different systemic antibiotics were used during the study period. Antibiotics that could be injected accounted for 59.0-99.8%. beta-Lactam antibacterials (ATC codes J01C and J01D) were the most used subgroups. The numbers of antimi...</description>
            <author>International Journal of Antimicrobial Agents</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1616379</comments>
            <pubDate>Mon, 07 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1616379</guid>        </item>
        <item>
            <title>Spectrophotometeric determination of cefuroxime axetil from bulk and in its tablet dosage form</title>
            <link>http://www.medworm.com/index.php?rid=1546442&amp;cid=c_8_13_f&amp;fid=33846&amp;url=http%3A%2F%2Fwww.ijpsonline.com%2Farticle.asp%3Fissn%3D0250-474X%3Byear%3D2008%3Bvolume%3D70%3Bissue%3D2%3Bspage%3D249%3Bepage%3D251%3Baulast%3DShinde</link>
            <description>Shinde MV, Pishawikar SA, More HNIndian Journal of Pharmaceutical Sciences 2008 70(2):249-251 (Source: Indian Journal of Pharmaceutical Sciences)</description>
            <author>Indian Journal of Pharmaceutical Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1546442</comments>
            <pubDate>Thu, 26 Jun 2008 21:32:27 +0100</pubDate>
            <guid isPermaLink="false">1546442</guid>        </item>
        <item>
            <title>Cefuroxime And Dextrose(Cefuroxime Sodium And Dextrose Monohydrate) Injection [B. Braun]</title>
            <link>http://www.medworm.com/index.php?rid=1536736&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D7621</link>
            <description>Updated Date: Jun 17, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1536736</comments>
            <pubDate>Sun, 22 Jun 2008 08:52:28 +0100</pubDate>
            <guid isPermaLink="false">1536736</guid>        </item>
        <item>
            <title>Restoration of susceptibility of intracellular Methicillin Resistant Staphylococcus aureus (MRSA) to {beta}-lactams: comparison between strains, cells, and antibiotics.</title>
            <link>http://www.medworm.com/index.php?rid=1586853&amp;cid=c_8_77_f&amp;fid=37538&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18519727%26dopt%3DAbstract</link>
            <description>Authors: Lemaire S, Olivier A, Van Bambeke F, Tulkens PM, Appelbaum PC, Glupczynski Y
    S. aureus invades eukaryotic cells. MRSA ATCC 33591 phagocytized by human THP-1 macrophages shows complete restoration of susceptibility to cloxacillin and meropenem, becoming indistinguishable from MSSA ATCC 25923 due to the acid pH prevailing in phagolysosomes (Lemaire et al., Antimicrob. Agents Chemother. 51:1627-32, 2007). We have examined whether this observation can be extended to (i) strains of current clinical and epidemiological interest (3 HA-MRSA; 2 CA-MRSA; 2 HA-MRSA with VISA phenotype; 1 HA-MRSA with VRSA phenotype; 1 animal [porcine] MRSA); (ii) activated THP-1 cells and non-professional phagocytes (keratinocytes, CALU-3 bronchial epithelial cells); (iii) other beta-lactams (imipenem, o...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Antimicrobial Agents and Chemotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1586853</comments>
            <pubDate>Mon, 02 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1586853</guid>        </item>
        <item>
            <title>Urine dipstick as a screening test for urinary tract infection.</title>
            <link>http://www.medworm.com/index.php?rid=1586218&amp;cid=c_8_159_f&amp;fid=37524&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18510821%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Urine dipstick should be promoted as a screening test for UTI. First-line use of cotrimoxazole and ampicillin for UTI should be reviewed.
    PMID: 18510821 [PubMed - in process] (Source: Annals of Tropical Paediatrics)</description>
            <author>Annals of Tropical Paediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1586218</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1586218</guid>        </item>
        <item>
            <title>The Timing of Surgical Antimicrobial Prophylaxis.</title>
            <link>http://www.medworm.com/index.php?rid=1472176&amp;cid=c_8_43_f&amp;fid=34290&amp;url=http%3A%2F%2Fwww.annalsofsurgery.com%2Fpt%2Fre%2Fannos%2Fabstract.00000658-200806000-00003.htm</link>
            <description>Under today&amp;#x0027;s recommendations, surgical antimicrobial prophylaxis may be administered within the final 2 hours before skin incision for optimal prevention of surgical site infections. The following prospective cohort study assessing 3836 consecutive surgical procedures provides observational evidence that administration of cefuroxime 59 to 30 minutes before incision is more effective than administration during the last half hour.Page: 918DOI: 10.1097/SLA.0b013e31816c3fecAuthors: Weber, Walter P. MD *; Marti, Walter R. MD, FACS *; Zwahlen, Marcel PhD +; Misteli, Heidi MD *; Rosenthal, Rachel MD *; Reck, Stefan MD *; Fueglistaler, Philipp MD *; Bolli, Martin MD *; Trampuz, Andrej MD ++; Oertli, Daniel MD, FACS *; Widmer, Andreas F. MD ++ (Source: Annals of Surgery)</description>
            <author>Annals of Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1472176</comments>
            <pubDate>Wed, 28 May 2008 15:14:10 +0100</pubDate>
            <guid isPermaLink="false">1472176</guid>        </item>
        <item>
            <title>Moxifloxacin monotherapy versus ceftriaxone plus levofloxacin in the treatment of CAP</title>
            <link>http://www.medworm.com/index.php?rid=1468450&amp;cid=c_8_13_f&amp;fid=32547&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2FRecord%2520Viewing%2FviewRecord.aspx%3Fid%3D593711</link>
            <description>This study was financially supported by Bayer HealthCare AG.

[Editor’s note: the comparator regimen used in this study does not represent current UK guidelines; the March 2008 BNF recommends that severe CAP should be treated with cefuroxime (or cefotaxime) plus a macrolide] (Source: NeLM Headline News)</description>
            <author>NeLM Headline News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1468450</comments>
            <pubDate>Tue, 27 May 2008 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">1468450</guid>        </item>
        <item>
            <title>Cefuroxime And Dextrose(Cefuroxime Sodium) Injection [B. Braun]</title>
            <link>http://www.medworm.com/index.php?rid=1464075&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D7376</link>
            <description>Updated Date: May 22, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1464075</comments>
            <pubDate>Thu, 22 May 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1464075</guid>        </item>
        <item>
            <title>Epidemiological survey on 
 Escherichia coli
 O157 in Chongqing and Three-Gorge Reservoir Areas of China</title>
            <link>http://www.medworm.com/index.php?rid=1449660&amp;cid=c_8_80_f&amp;fid=36011&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3455474888183t85%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Prevalence, presence of virulence and adherence associated genes, genetic diversity, biochemical characteristics, and antibiotic
 susceptibility were determined for Escherichia coli O157 isolated over 4 months in Chongqing city and Three-Gorge Reservoir Areas. 11 isolates of E. coli O157 were isolated from 1504 samples and 7 of them are O157:H7 and 4 are O157:H? All O157:H7 isolates had eaeA, ehxA, EspA and Tccp genes, but did not have stx1 and stx2. All O157:H? isolates did not have stx1, stx2, eaeA, ehxA, EspA and Tccp genes except for the isolate obtained from Yunyang county which had stx1. When eaeA and ehxA presented in isolates were digested by restriction enzymes, the numbers and the sizes of the segments were the same as the
 control E. coli O157 strains. This s...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Veterinary Research Communications</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1449660</comments>
            <pubDate>Thu, 15 May 2008 06:13:21 +0100</pubDate>
            <guid isPermaLink="false">1449660</guid>        </item>
        <item>
            <title>Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia</title>
            <link>http://www.medworm.com/index.php?rid=1422431&amp;cid=c_8_6_f&amp;fid=33593&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fcncr.23563</link>
            <description>The aim of this study was to determine whether antibiotic prophylaxis during periods of neutropenia reduced streptococcal (S. viridans) sepsis and overall bacterial sepsis.The authors reviewed outcomes of 78 evaluable patients who were consecutively treated for acute myeloid leukemia (AML) from October 2002 through January 2007. Several successive prophylactic antibiotic regimens were used. All patients received antifungal prophylaxis with oral voriconazole.Oral cephalosporins did not significantly reduce the odds of bacterial sepsis (P = .81) or streptococcal (S. viridans) sepsis (P = .90) relative to no prophylaxis. Intravenous (iv) cefepime completely prevented streptococcal (S. viridans) sepsis and reduced the odds of bacterial sepsis 91% (P &lt; .0001) relative to no prophylaxis, but res...</description>
            <author>Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1422431</comments>
            <pubDate>Mon, 05 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1422431</guid>        </item>
        <item>
            <title>Effect of malnutrition on the pharmacokinetics of cefuroxime axetil in young rats.</title>
            <link>http://www.medworm.com/index.php?rid=1412950&amp;cid=c_8_13_f&amp;fid=32523&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18445361%26dopt%3DAbstract</link>
            <description>Conclusions: The pharmacokinetics of cefuroxime was affected by malnutrition, suggesting that the absorption process via the transporter was modified in the malnourished groups, specially in the group fed with a low quality protein.
    PMID: 18445361 [PubMed - in process] (Source: J Pharm Pharm Sci)</description>
            <author>J Pharm Pharm Sci</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1412950</comments>
            <pubDate>Thu, 01 May 2008 19:54:47 +0100</pubDate>
            <guid isPermaLink="false">1412950</guid>        </item>
        <item>
            <title>Diagnosis and treatment of lyme disease.</title>
            <link>http://www.medworm.com/index.php?rid=1418596&amp;cid=c_8_49_f&amp;fid=36819&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18452688%26dopt%3DAbstract</link>
            <description>Authors: Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD
    Lyme disease is the most common tick-borne disease in the United States. This review details the risk factors, clinical presentation, treatment, and prophylaxis for the disease. Information was obtained from a search of the PubMed and MEDLINE databases (keyword: Lyme disease) for articles published from August 31, 1997, through September 1, 2007. Approximately 20,000 cases of Lyme disease are reported annually. Residents of the coastal Northeast, northwest California, and the Great Lakes region are at highest risk. Children and those spending extended time outdoors in wooded areas are also at increased risk. The disease is transmitted to humans through the bite of the Ixodes tick (Ixodes scapularis and Ixodes pacificus)....</description>
            <author>Mayo Clinic Proceedings</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1418596</comments>
            <pubDate>Thu, 01 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1418596</guid>        </item>
        <item>
            <title>Loss of enzyme activity during turnover of the Bacillus cereus beta-lactamase catalysed hydrolysis of beta-lactams due to loss of zinc ion.</title>
            <link>http://www.medworm.com/index.php?rid=1564969&amp;cid=c_8_59_f&amp;fid=37322&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18449576%26dopt%3DAbstract</link>
            <description>Authors: Badarau A, Page MI
    Metallo-beta-lactamases are zinc-ion-dependent and are known to exist either as mononuclear or as dinuclear enzymes. The kinetics and mechanism of hydrolysis of the native zinc Bacillus cereus metallo-beta-lactamase (BcII) have been investigated under pre-steady-state conditions at different pHs and zinc-ion concentrations. Biphasic kinetics are observed for the hydrolysis of cefuroxime and benzylpenicillin with submicromolar concentrations of enzyme and zinc. The initial burst of product formation far exceeds the concentration of enzyme and the subsequent slower rate of hydrolysis is attributed to a branched kinetic pathway. The pH and metal-ion dependence of the microscopic rate constants of this branching were determined, from which it is concluded that t...</description>
            <author>Journal of Biological Inorganic Chemistry : JBIC</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1564969</comments>
            <pubDate>Thu, 01 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1564969</guid>        </item>
        <item>
            <title>[Original articles] Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis</title>
            <link>http://www.medworm.com/index.php?rid=1398267&amp;cid=c_8_32_f&amp;fid=28429&amp;url=http%3A%2F%2Fjcp.bmj.com%2Fcgi%2Fcontent%2Ffull%2F61%2F5%2F642%3Frss%3D1</link>
            <description>Conclusion:
The prevalence of plasmid-mediated ampC was high in the study population, and may be missed by conventional susceptibility testing methods. Inhibitor-based screening methods would improve detection of this emerging resistance phenotype. (Source: Journal of Clinical Pathology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Clinical Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1398267</comments>
            <pubDate>Fri, 25 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1398267</guid>        </item>
        <item>
            <title>Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability.</title>
            <link>http://www.medworm.com/index.php?rid=1469916&amp;cid=c_8_13_f&amp;fid=35550&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18502628%26dopt%3DAbstract</link>
            <description>Authors: Dhumal RS, Biradar SV, Yamamura S, Paradkar AR, York P
    The aim of the present work was to prepare amorphous discreet nanoparticles by sonoprecipitation method for enhancing oral bioavailability of cefuroxime axetil (CA), a poorly water-soluble drug. CA nanoparticles (SONO-CA) were prepared by sonoprecipitation and compared with particles obtained by precipitation without sonication (PPT-CA) and amorphous CA obtained by spray drying. Spray drying present broad particle size distribution (PSD) with mean particle size of 10mum and low percent yield, whereas, precipitation without sonication resulted in large amorphous aggregates with broad PSD. During sonoprecipitation, particle size and yield improve with an increase in the amplitude of sonication and lowering the operation temp...</description>
            <author>European Journal of Pharmaceutics and Biopharmaceutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1469916</comments>
            <pubDate>Fri, 11 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1469916</guid>        </item>
        <item>
            <title>Neonatal septicaemia in Calabar, Nigeria.</title>
            <link>http://www.medworm.com/index.php?rid=1423865&amp;cid=c_8_159_f&amp;fid=36148&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18453516%26dopt%3DAbstract</link>
            <description>Authors: Anah MU, Udo JJ, Ochigbo SO, Abia-Bassey LN
    A three-year survey of neonatal septicaemia (363 bacteriologically proven cases) in the University of Calabar Teaching Hospital, Calabar, has demonstrated that the dominant blood isolate was Staphylococcus aureus (53%) followed by unclassified Coliforms (20%), an unexpected Chromobacterium violaceum (5%). The incidence of neonatal septicaemia was 54.9 per 1000 live births for inborn infants. The predominant organisms were largely susceptible to gentamicin, ceftriazone and cefuroxime with a mortality rate of 19% with most (60.9%) of the fatalities being due to Gram-negative organisms.
    PMID: 18453516 [PubMed - in process] (Source: Tropical Doctor)</description>
            <author>Tropical Doctor</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1423865</comments>
            <pubDate>Tue, 01 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1423865</guid>        </item>
        <item>
            <title>Antimicrobial susceptibility of Haemophilus influenzae strains and antibiotics usage patterns in pediatric outpatients: results from a children's hospital in China (2000-2004)</title>
            <link>http://www.medworm.com/index.php?rid=1318716&amp;cid=c_8_40_f&amp;fid=33612&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fppul.20789</link>
            <description>To investigate the nasopharyngeal carriage and antimicrobial susceptibility of H. influenzae among children younger than 5 years old and to assess antibiotics usage patterns in the outpatient department of Beijing Children's Hospital from 2000 to 2004.From 2000 to 2004, At least 100 strains of H. influenzae were isolated from the pediatric patients who were younger than 5 years and who presented with symptoms of acute upper respiratory tract infections during February to May in each of the study years. Antimicrobial susceptibilities were determined; and antibiotics usage was expressed as defined daily dose (DDD)/100 patient days.The overall nasopharyngeal carriage rate of H. influenzae is 26.3% (562/2,137) in children younger than 5 years old with acute upper respiratory tract infection. T...</description>
            <author>Pediatric Pulmonology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1318716</comments>
            <pubDate>Fri, 21 Mar 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1318716</guid>        </item>
        <item>
            <title>Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of 
 Streptococcus pneumoniae
 among Beijing children with upper respiratory infections (2000–2005)</title>
            <link>http://www.medworm.com/index.php?rid=1313824&amp;cid=c_8_77_f&amp;fid=33419&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx6l2000257783u1w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aims of this study were to estimate pneumococcal carriage rate, antimicrobial resistance and serogroup distribution of
 nasopharyngeal isolates of Streptococcus pneumoniae among children with acute upper respiratory infections (AURIs) aged 1&amp;nbsp;month to 5&amp;nbsp;years attending outpatient department of
 the Beijing Children’s Hospital between 2000 and 2005. Susceptibilities to penicillin, amoxicillin-clavulanic acid, ceftriaxone,
 cefuroxime, cefaclor, erythromycin, tetracycline, sulfamethoxazole-trimethoprim and chloramphenicol were assessed using the
 E-test and disc diffusion. We also analyzed the correlation between antibiotic consumption and rates of resistance. The prevalence
 of penicillin-nonsusceptible pneumococci increased from 26% during 2000–2001 and...</description>
            <author>European Journal of Clinical Microbiology &amp; Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1313824</comments>
            <pubDate>Tue, 18 Mar 2008 08:14:28 +0100</pubDate>
            <guid isPermaLink="false">1313824</guid>        </item>
        <item>
            <title>Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=1319466&amp;cid=c_8_77_f&amp;fid=35514&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18353594%26dopt%3DAbstract</link>
            <description>Authors: Biedenbach DJ, Jones RN, Fritsche TR
    Among orally administered cephalosporins, aminopenicillins (+/-clavulanate), and macrolides, cefditoren was the most potent agent against Haemophilus influenzae (MIC(50/90), &amp;lt;/=0.008/0.03 mug/mL; 316 isolates including 100 beta-lactamase-positive and 10 beta-lactamase-negative ampicillin-resistant [BLNAR]) and was 32-, 64-, and 512-fold more potent than cefdinir, cefuroxime, and cefprozil, respectively. Cefditoren (MIC(50), 0.03 mug/mL) was also &amp;gt;/=32-fold more active against BLNAR phenotypes, although newer macrolides provided complete coverage against these strains. All Moraxella catarrhalis isolates were inhibited by cefditoren (0.5 mug/mL), including beta-lactamase producers (MIC(50), 0.12 vs &amp;lt;/=0.008 mug/mL). Cefditoren retain...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Diagnostic Microbiology and Infectious Disease</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1319466</comments>
            <pubDate>Tue, 18 Mar 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1319466</guid>        </item>
        <item>
            <title>Cefuroxime Axetil(Cefuroxime Axetil) Tablet, Film Coated [ORCHID HEALTHCARE (A DIVISION OF ORCHID CHEMICALS AND PHARMACEUTICALS LTD.)]</title>
            <link>http://www.medworm.com/index.php?rid=1280939&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D6655</link>
            <description>Updated Date: Mar 5, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1280939</comments>
            <pubDate>Wed, 05 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1280939</guid>        </item>
        <item>
            <title>[Efficacy of cefditoren in the treatment of upper respiratory tract infections: a pooled analysis of six clinical trials.]</title>
            <link>http://www.medworm.com/index.php?rid=1568724&amp;cid=c_8_13_f&amp;fid=37253&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18443928%26dopt%3DAbstract</link>
            <description>Conclusion. Cefditoren had similar point estimates of clinical efficacy to comparators in pharyngotonsillitis and sinusitis, and a tendency to higher S. pyogenes eradication in pharyngotonsillitis. Key words: Cefditoren. S. pyogenes. Clinical trial. Pooled analysis. Sinusitis. Pharyngotonsillitis. Rev Esp Quimioter 2008;21(1):14-21.
    PMID: 18443928 [PubMed - in process] (Source: Revista Espanola de Quimioterapia)</description>
            <author>Revista Espanola de Quimioterapia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1568724</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1568724</guid>        </item>
        <item>
            <title>Using intracameral cefuroxime as a prophylaxis for endophthalmitis.</title>
            <link>http://www.medworm.com/index.php?rid=1820372&amp;cid=c_8_30_f&amp;fid=38068&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18504469%26dopt%3DAbstract</link>
            <description>Authors: Yorston D
    
    PMID: 18504469 [PubMed - in process] (Source: Community Eye Health)</description>
            <author>Community Eye Health</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1820372</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1820372</guid>        </item>
        <item>
            <title>Ranbaxy Laboratories has received US FDA approval for the manufacture and marketing of cefuroxime axetil for oral suspension USP.</title>
            <link>http://www.medworm.com/index.php?rid=1246543&amp;cid=c_8_13_f&amp;fid=34370&amp;url=http%3A%2F%2Finpharma.adisonline.com%2Fpt%2Fre%2Finp%2Fabstract.00128413-200816250-00063.htm</link>
            <description>Page: 22 (Source: Inpharma Weekly)</description>
            <author>Inpharma Weekly</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1246543</comments>
            <pubDate>Thu, 21 Feb 2008 08:46:23 +0100</pubDate>
            <guid isPermaLink="false">1246543</guid>        </item>
        <item>
            <title>Ranbaxy Laboratories has received US FDA approval for the manufacture and marketing of cefuroxime axetil for oral suspension USP</title>
            <link>http://www.medworm.com/index.php?rid=1239539&amp;cid=c_8_13_f&amp;fid=33934&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Finp%2F2008%2F00000001%2F00001625%2Fart00063</link>
            <description>(Source: Inpharma)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Inpharma</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1239539</comments>
            <pubDate>Tue, 19 Feb 2008 07:50:03 +0100</pubDate>
            <guid isPermaLink="false">1239539</guid>        </item>
        <item>
            <title>Minimum requirements for a rapid and reliable routine identification and antibiogram of 
 Fusobacterium necrophorum</title>
            <link>http://www.medworm.com/index.php?rid=1241333&amp;cid=c_8_77_f&amp;fid=33419&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq384r113w488h377%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Three hundred fifty-seven isolates of Fusobacterium necrophorum from human infections in Denmark were consecutively collected over a 3 year period for the purpose of establishing the minimum
 requirements for rapid and reliable routine identification of Fusobacterium necrophorum using phenotypic characters. The first 40 isolates were fully characterized by the most common phenotypic tests mentioned
 in the literature, while the last 317 where identified solely by the established minimum requirements for rapid and reliable
 routine identification of Fusobacterium necrophorum. All but one isolate were identical in all phenotypic tests. The outlying strain differed in morphology and the ability to
 agglutinate erythrocytes. On the basis of our findings it should be possibl...</description>
            <author>European Journal of Clinical Microbiology &amp; Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1241333</comments>
            <pubDate>Sun, 17 Feb 2008 05:24:39 +0100</pubDate>
            <guid isPermaLink="false">1241333</guid>        </item>
        <item>
            <title>Effect of severity disease on the pharmacokinetics of cefuroxime in children with multiple organ system failure.</title>
            <link>http://www.medworm.com/index.php?rid=1196427&amp;cid=c_8_13_f&amp;fid=32516&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18239295%26dopt%3DAbstract</link>
            <description>Authors: Olguin HJ, Asseff IL, Vieyra AC, P&amp;#xE9;rez AG, Salda&amp;#xF1;a NG, Quesada AC, Guill&amp;#xE9; GP
    The aim of the present study was to investigate if the severity of illness affected the pharmacokinetics of cefuroxime in 11 children diagnosed with multiple organ system failure. The patients were assigned to a severely ill group (group 1), a very severely ill group (group 2), or a control group (group 0). Blood samples were taken and cefuroxime concentrations were measured in plasma by HPLC after the first intravenous infusion of 100 mg of cefuroxime per kg of body weight. The pharmacokinetic profile of cefuroxime exhibited both one and two compartmental distribution. Statistically significant differences between the pharmacokinetic parameters of the severe (group 1) and the very seve...</description>
            <author>Biological and Pharmaceutical Bulletin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1196427</comments>
            <pubDate>Fri, 01 Feb 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1196427</guid>        </item>
        <item>
            <title>Clinical application of the rapid pneumococcal urinary antigen test in the treatment of severe pneumonia in children.</title>
            <link>http://www.medworm.com/index.php?rid=1293659&amp;cid=c_8_77_f&amp;fid=33090&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18327425%26dopt%3DAbstract</link>
            <description>CONCLUSION: Application of PUAT and adequate antimicrobial treatments in the initial stage for pediatric patients with severe pneumonia resulted in improved outcome as assessed by shortening of the duration of fever.
    PMID: 18327425 [PubMed - in process] (Source: Journal of Microbiology, Immunology, and Infection)</description>
            <author>Journal of Microbiology, Immunology, and Infection</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1293659</comments>
            <pubDate>Fri, 01 Feb 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1293659</guid>        </item>
        <item>
            <title>Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old.</title>
            <link>http://www.medworm.com/index.php?rid=1573589&amp;cid=c_8_18_f&amp;fid=37367&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18283233%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: When a favorable clinical or biochemical response occurs on day 3 of IV cefuroxime therapy, further therapy with oral cefuroxime-axetil is as effective and safe as a full course of cefuroxime IV in elderly patients hospitalized with CALRTI. However, LOS was not reduced after sequential antibiotic therapy in this population.
    PMID: 18283233 [PubMed - indexed for MEDLINE] (Source: Aging Clinical and Experimental Research)</description>
            <author>Aging Clinical and Experimental Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1573589</comments>
            <pubDate>Fri, 01 Feb 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1573589</guid>        </item>
        <item>
            <title>Moxifloxacin equals ceftriaxone + cefuroxime in pneumonia</title>
            <link>http://www.medworm.com/index.php?rid=1183367&amp;cid=c_8_13_f&amp;fid=33934&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Finp%2F2008%2F00000001%2F00001622%2Fart00032</link>
            <description>(Source: Inpharma)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Inpharma</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1183367</comments>
            <pubDate>Tue, 29 Jan 2008 07:49:57 +0100</pubDate>
            <guid isPermaLink="false">1183367</guid>        </item>
        <item>
            <title>Moxifloxacin equals ceftriaxone + cefuroxime in pneumonia.</title>
            <link>http://www.medworm.com/index.php?rid=1178830&amp;cid=c_8_13_f&amp;fid=34370&amp;url=http%3A%2F%2Finpharma.adisonline.com%2Fpt%2Fre%2Finp%2Fabstract.00128413-200816220-00033.htm</link>
            <description>Page: 11 (Source: Inpharma Weekly)</description>
            <author>Inpharma Weekly</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1178830</comments>
            <pubDate>Sat, 26 Jan 2008 08:35:40 +0100</pubDate>
            <guid isPermaLink="false">1178830</guid>        </item>
        <item>
            <title>Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli.</title>
            <link>http://www.medworm.com/index.php?rid=1177213&amp;cid=c_8_13_f&amp;fid=32517&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18215351%26dopt%3DAbstract</link>
            <description>Conclusion: This is the first report of these 5 novel plasmid-mediated CTX-M ESBL produced from China in the world. Molecular typing reveals notably different origin in genes encoding different CTX-M variants of 8 strains.
    PMID: 18215351 [PubMed - in process] (Source: Acta Pharmacologica Sinica)</description>
            <author>Acta Pharmacologica Sinica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1177213</comments>
            <pubDate>Fri, 25 Jan 2008 20:58:16 +0100</pubDate>
            <guid isPermaLink="false">1177213</guid>        </item>
        <item>
            <title>Cefuroxime Axetil(Cefuroxime Axetil) Tablet [Aurobindo Pharma Limited]</title>
            <link>http://www.medworm.com/index.php?rid=1177852&amp;cid=c_8_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D6165</link>
            <description>Updated Date: Jan 25, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1177852</comments>
            <pubDate>Fri, 25 Jan 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1177852</guid>        </item>
        <item>
            <title>Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4</title>
            <link>http://www.medworm.com/index.php?rid=1148598&amp;cid=c_8_77_f&amp;fid=28434&amp;url=http%3A%2F%2Fwww.ann-clinmicrob.com%2Fcontent%2F7%2F1%2F1</link>
            <description>Conclusions:
Over the first 4 years of PROTEKT US, penicillin and erythromycin resistance among pneumococcal isolates has remained high. Although macrolide resistance rates have stabilized, the prevalence of clonal isolates, with a combined erm(B) and mef(A) genotype together with high-level macrolide and multidrug resistance, is increasing, and their spread may have serious health implications. Telithromycin and levofloxacin both showed potent in vitro activity against S. pneumoniae isolates irrespective of macrolide resistance genotype. (Source: Annals of Clinical Microbiology and Antimicrobials)</description>
            <author>Annals of Clinical Microbiology and Antimicrobials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1148598</comments>
            <pubDate>Fri, 11 Jan 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1148598</guid>        </item>
    </channel>
</rss>
